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ABSTRACT
Polyynes, or acetylenic scaffolds, are often found as core structures in various natural 
products and exhibit biological properties such as antibacterial, antifungal, and anti- 
cancerous activity. This research develops a new methodology, a solid-supported Glaser- 
Hay reaction, alleviating the standard chemoselectivity issues associated with the Glaser- 
Hay reaction and providing a means to synthesize these polyyne structures in a 
chemoselective fashion. To extend the biological benefits of the solid-supported Glaser- 
Hay reaction, this methodology is then employed toward the synthesis of natural products. 
Furthermore, utilizing unnatural amino acid technology, this reaction can be transferred 
to a biological context, serving as a novel bioconjugation method and providing a new 
methodology for potential therapeutic applications.
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Chapter 1- Introduction to Unnatural Amino Acids
I. Expanding the Genetic Code
Amino acids possess both a carboxylic acid and an amino functionality that 
facilitate their polymerization to form peptide bonds. Consequently, these functional 
molecules comprise the fundamental building blocks of proteins. Overall, amino acids 
play an important role in determining protein function, as well as in cell signaling, gene 
expression, and hormone synthesis.1 With 20 canonical amino acids, the potential 
number of proteins afforded by their combination in different number and sequence 
provides a wide array of protein structures and functions. However, it would be beneficial 
to add new amino acids to this makeup, allowing for varied or improved post-translational 
protein function, new therapeutic methods, insights into numerous biological processes, 
and the production of new proteins or organisms.2 Therefore, a substantial amount of 
research has been conducted to introduce unnatural amino acids (UAAs) in a specific 
fashion into the sequence of a protein. UAAs allow for the expansion of the genetic code, 
affording routes for further control of known protein functions as well as a methodology 
for generating new proteins with enhanced structure and function. To date, hundreds of 
amino acid derivatives have been synthesized to include functionalities such as metal 
binders, azides, fluorophores, photolabile groups, and alkynes.2 These functional groups 
allow for a vast array of new probes for characterization, bioconjugation methods, and
medicinal and therapeutic studies. Overall, the utilization of unnatural amino acids allows 
for novel protein research.
II. Protein Translation
Translation is an intricate biological process that involves three main steps: 
initiation, termination, and elongation. During initiation, the functional ribosome is 
assembled in response to a special initiation codon in the mRNA. Next, during elongation, 
aminoacyl-tRNAs (aa-tRNA) enter the process and are used as delivery devices. The aa- 
tRNA binds an amino acid ("charges" the amino acid) and delivers the AA to the ribosome 
for incorporation into the growing polypeptide chain in response to a specific codon. In 
order to function correctly, the aminoacyl-tRNA must be properly charged with an amino 
acid as well as contain the proper codon for recognition of the mRNA site. The ribosome 
then catalyzes the formation of a growing polypeptide chain which continues to elongate 
with each sequential codon. Finally, during termination, a stop codon is reached, and the 
newly formed polypeptide chain is released from the ribosome.3 (Figure 1.1)
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Figure 1.1: Each tRNA is charged with the appropriate amino acid, then responds to a 
specific anticodon located on the mRNA template. The polypeptide chain continues 
growing until a stop codon is reached on the mRNA. 4
In order for this process to be successful, it is necessary that the tRNA is properly 
charged with the correct amino acid, as each tRNA harbors a specific anticodon that 
allows for the translation of the nucleic acid message into a protein context. This process 
is done by an aminoacyl tRNA synthetase (aaRS) that loads a specific amino acid onto an 
isoacceptor tRNA. Each amino acid requires a unique aaRS for charging its isoacceptor 
tRNA that is said to be orthogonal to the other aaRSs. Once properly loaded, the 
aminoacyl-tRNA can then base-pair with the proper codon located on the mRNA.5 
Intricate translational machinery then is employed in order to form peptide bonds 
between the growing chain of amino acids, and the process is terminated when the stop 
codon located in the mRNA is reached.
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III. Manipulating Translational Machinery to Incorporate UAA's
There have been many methodologies proposed for incorporation of UAAs in vivo, 
with one of the most accepted and successful approaches being established by the Schultz 
laboratory. Overall, this method manipulates the natural translational machinery of 
proteins in order to site-specifically incorporate the desired UAA.
As previously described, each amino acid is charged onto a specific aminoacyl- 
tRNA that responds to its codon on the mRNA in order to insert an amino acid and 
generate a polypeptide chain. The Schultz method exploits this machinery in order to 
incorporate an unnatural amino acid. To begin, the UAA must be charged specifically onto 
the aminoacyl-tRNA. It is necessary for this tRNA to not be recognized by any native 
aminoacyl-tRNA synthetases in order to prevent the loading of native amino acids to the 
tRNA. Also required is an aminoacyl-tRNA synthetase (aaRS) that will not recognize native 
aminoacyl-tRNAs. This independence from the endogenous system is often referred to as 
being "orthogonal" to the other aaRSs and tRNAs. An efficient method for generating an 
orthogonal aaRS/tRNA pair for use in E. coli is importing an already existing pair from a 
eukaryote or archaeon.6 In doing so, the new aaRS will not charge native amino acids onto 
the tRNA of the E. coli, and similarly, the native E. coli aaRSs will not recognize the foreign 
tRNA. To date, several of these orthogonal aaRS/tRNA pairs have undergone a selection 
process and have been adapted for use in E. coli.6
The selection process was initially performed using an aaRS/tRNA pair from the
archaea Methanocoldococcus jannaschii, M/TyrRS//V7/'tRNATyr.9 In order to alter the aaRS,
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(here the /W/TyrRS) to specifically recognize a desired unnatural amino acid, a large library 
of the mutant /W/TyrRS was prepared and underwent a two-step selection process 
involving both a positive and a negative selection step. (Figure 1.2)
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Figure 1.2: Demonstration of the selection process to produce a mutant /W/TyrRS//W/tRNA 
pair that will successfully incorporate a specific unnatural amino acid. This process is 
completed 2.5 times, ultimately ending on a positive selection step.
In step one of the selection process, the mutant cells transformed with an 
aaRS/tRNA pair are grown in the presence of chloramphenicol and the desired unnatural 
amino acid to assess which mutants have the ability to suppress the amber stop codon 
(TAG) and successfully insert an amino acid. If the TAG codon is suppressed and the amino 
acid inserted, the cells will carry the gene for resistance to choloramphenicol (chlor) and 
therefore will survive. Any cells not surviving did not possess the ability to successfully 
suppress the TAG codon and will die in the presence of chlor. Therefore, survivors of this
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step are mutant /W/TyrRS that can successfully aminoacylate /W/tRNA with the desired 
UAA or an endogenous amino acid. These survivors then undergo a negative selection 
step to further provide selective /W/TyrRS mutants, eliminating those that accept an 
endogenous amino acid. In this step, the mutant aaRS/tRNA are grown without the 
unnatural amino acid, and any pairs that suppress the inserted TAG codons of the barnase 
gene and insert an endogenous amino acid are eliminated due to the production and 
toxicity of barnase.9 Survivors of this step then undergo the entire process again and 
ultimately end on a positive selection step, ultimately producing a very selective 
/W/TyrRS//W/tRNATyr pair for unnatural amino acid incorporation. If the selection process 
is not completed correctly or enough rounds are not performed, the aaRS/tRNA pair may 
not be completely selective and is referred to as 'promiscuous,' meaning that this 
synthetase has the ability to charge numerous amino acids to the tRNA.
Moving forward, in order for the orthogonal aaRS/tRNA machinery to be effective
in vivo, there must be a codon located on the mRNA that recognizes the anticodon for the
orthogonal tRNA charged with the UAA. This provides site-specific incorporation of the
UAA based on the mRNA sequence. The degeneracy in the genetic code proves extremely
beneficial in this step of the methodology. Because there are four nucleotides and three
nucleotides make up any given codon, there are a possible sixty four codons (43); sixty
one of these codons are associated with one of the twenty amino acids, and three are
recognized as stop codons. Fortuitously, the TAG codon (amber stop codon) is a
degenerate codon that denotes termination and can be exploited in order to site-
specifically incorporate unnatural amino acids.5 This is achieved by mutating the DNA that
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produces the mRNA to include the TAG codon. The tRNA charged with the UAA then is 
able to complimentarily base pair to the TAG region, allowing transcriptional machinery 
to continue the process, and incorporating the UAA site-specifically. (Figure 1.3) If there 
is no amino acid present, translation is terminated in response to the TAG stop codon.
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Figure 1.3: Normal translation can be seen on the left, where a tRNA synthetase charges 
a specific amino acid to the tRNA, which then base pairs with its anticodon in the mRNA 
template and inserts the amino acid into the expanding polypeptide chain. On the right, 
an introduced orthogonal tRNA synthetase charges the orthogonal tRNA with the
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unnatural amino acid, and specifically responds to a mutated codon in order to base pair 
with the mRNA and allow translation to continue, site-specifically incorporating the UAA.7
In order to utilize this developed technology, E. coli must be transformed with two 
separate plasmids, one encoding for the orthogonal aaRS/tRNA pair, as well as one 
encoding for the mutant protein of choice containing the TAG codon. As mentioned, it is 
possible for the orthogonal synthetase to be 'promiscuous.' This degree of promiscuity 
can, at times, prove beneficial. When attempting to incorporate a newly described 
unnatural amino acid, the researcher may run a screen of created synthetase/tRNA pairs 
in hopes that an already evolved pair will charge their UAA appropriately. This eliminates 
the need for a tedious selection process for every single created UAA, and may provide a 
quick route for the incorporation of numerous UAAs.8 Once transformed with both the 
orthogonal aaRS/tRNA and mutant protein, cells containing these plasmids can be grown 
on a plate containing antibiotics associated with both plasmids, and only cells that have 
successfully been transformed with both are able to survive. Colonies can then be chosen 
for expression with the desired UAA. Once the UAA is introduced, it will be site-specifically 
incorporated at the mutated TAG site of the protein, or conversely, when not expressed 
with the UAA, translation of the protein will be terminated by the amber stop codon. This 
feature allows for a viable control method determining if the desired UAA was site- 
specifically incorporated. Overall, this methodology is a useful mechanism for the specific 
introduction of UAA's in vivo, expanding the genetic code and allowing for new and 
exciting research on protein structure and function
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Chapter 2- Incorporation of a Terphenyl Unnatural Amino Acid
I. Introduction
A. Fluorescent Probes as Protein Markers
Introducing fluorescent probes into proteins is a useful tool to examine protein 
structure and function, as well as for facilitating visualization of cellular location of a given 
protein.1 To date, there are numerous known fluorescent probes that can be used to 
further our scientific understanding of different proteins and their cellular functions. 
These include small organic fluorescent dyes, nanocrystals (quantum dots), naturally 
occurring fluorescent proteins, and small genetically encoded tags that can be complexed 
with fluorophores.2 These probes may also be used in different combinations, allowing 
for a wide array of fluorescence studies in the fields of molecular biology, organic and 
analytical chemistry, and materials science.2 Different fluorophores possess unique 
spectral properties, and can therefore be multiplexed towards a wide array of protein 
applications. This necessitates the need for a plethora of known fluorophores with unique 
properties, as well as continued research to expand the number and physical/chemical 
properties of these fluorescent protein probes.3'5
There are varying mechanisms reported in literature that may be employed to 
introduce fluorescent probes into proteins. One noted method introduces a fluorophore 
to a protein post-translation via chemical modification.6 However, this methodology is 
limited to the number of surface-exposed, reactive residues on the protein that are
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available for attachment of the probe. Other limitations to this approach involve issues 
associated with non-specific labeling and a general lack of control over the sites that react 
with the fluorophore leading to complex mixtures both in residues and number of 
conjugated probes.6
Another reported methodology uses chemical modification of unique unnatural 
amino acid residues to afford a degree of specificity to the probe conjugation. Early 
studies employed chemically misacylated tRNA to introduce an unnatural amino acid. This 
amino acid residue could be the fluorophore itself, or could be further used to attach the 
desired probe. Using a misacylated tRNA approach to incorporate a UAA, however, 
affords limited protein yields and can only be performed on easily accessible positions on 
the protein.7,8'9 To avoid these standard limitations, an unnatural amino acid can be 
incorporated in vivo through the use of an amber suppression system developed in the 
Schultz laboratory.19 (See Chapter 1) Specifically, we aim to introduce a terphenyl UAA 
fluorescent probe into proteins (Figure 2.1) via this site-specific unnatural amino acid 
methodology. Moreover, we will investigate the role of the terphenyl UAA on the 
alteration of GFP fluorescence to illustrate its unique fluorescent properties.
Figure 2.1: Structure of terphenyl (4-biphenyl-L-phenylalanine)(4).
The proposed methodology utilizing an orthogonal tRNA and aminoacyl-tRNA 
synthetase (aaRS) to incorporate an UAA via response to an introduced TAG codon has 
long been used as a successful approach for incorporation of UAA's.10 Ideally, we hope to 
exploit the recently discovered promiscuity of aaRSs in order to obviate the need for an 
intensive aaRS evolution. We hypothesize that a promiscuous aaRS can effect site-specific 
incorporation of the terphenyl UAA to produce a novel terphenyl enhanced GFP.11
B. Benefits o f Terphenyl as a UAA
Due to the extensive n-conjugation within the structure of the terphenyl, this 
compound proves to be an ideal and interesting compound to use as a fluorescent probe 
in proteins. As a fluorophore, terphenyl displays photophysical properties and has been 
characterized and studied by various research groups. This molecule displays an emission 
wavelength of 342 nm and has been discovered to be sensitive to environmental 
conditions.12 Due to these properties, terphenyl has found use in multiple applications 
such as two-photon laser scanning microscopy,13 femtosecond fluorescence 
spectroscopy,14 and a-helical secondary structure investigations.15 By using these various 
methods of study, terphenyl has proven to be of use in expanding knowledge of charge 
transfer, isomerization, and protein dynamics within biological systems.
Furthermore, terphenyl UAA incorporation proves to be a useful mechanism for
fluorescence labeling of a desired protein. The terphenyl UAA, although containing a
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triphenyl moiety, is of relatively small size which allows for conformational mobility within 
the protein. Benefits of using terphenyl as a fluorescent UAA have recently been 
examined by Chen and co-workers.16,17 This group incorporated terphenyl and its 
derivatives into dihydrofolate reductase (DHFR) from Escherichia coli for FRET 
fluorescence studies. Their studies report the successful incorporation of terphenyl and 
an increased knowledge of changes in protein conformations and dynamics. However, the 
method of incorporation of the UAA involved chemically misacylated tRNAs. As previously 
discussed, this method can result in lower protein yields and requires tedious synthetic 
modifications of tRNAs. Due to the demonstrated beneficial application of terphenyl as 
an UAA, we set forth to incorporate terphenyl via the orthogonal tRNA and aminoacyl- 
tRNA synthetase system in order to completely incorporate it into the genetic code site- 
specifically, and study the unique effects this molecule displays in GFP.
II. Results and Discussion
A. Synthesis o f a Terphenyl UAA
Studies were initiated with the synthesis of the terphenyl UAA from an adapted 
literature protocol.17 An initial esterification of N-Boc-4-iodo-L-phenylalanine (1) with 
methyl iodide affords the protected methyl ester (2, 90% yield). A Suzuki cross coupling 
reaction was then employed with 4-biphenylboronic acid to yield the protected terphenyl 
unnatural amino acid (3). Lastly, the Boc and methyl protecting groups were removed via
LiOH and TFA to afford the fully deprotected 4-biphenyl-L-phenylalanine (4) (Scheme 2.1).
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Upon successful synthesis, the focus then shifted to incorporating this fluorescent 
UAA into the protein of choice. To date there are numerous synthetases that have been 
evolved to accept a wide array of UAAs.18'19 Therefore, we attempted to identify an aaRS 
that would recognize the terphenyl UAA and charge the corresponding orthogonal tRNA 
in order to incorporate the fluorescent probe into GFP.
B. Incorporation o f Terphenyl UAA into GFP
Green Fluorescent Protein (GFP) is a natural fluorescing protein that is originally 
isolated from a species of deep sea jellyfish, Aequorea victoria. GFP contains a natural, 
internal fluorophore which is located on an a-helix located in the inner protein structure. 
The fluorophore is surrounded by the outer p-barrels of the protein, that overall form a
14
cylindrical protein structure.22 Due to the extensive fluorescent properties and 
characteristics of GFP, it is often used as a reporter gene, cell marker, or a fusion tag for 
biochemical applications.22 Conveniently, our lab has access to GFP that has been 
mutated with TAG codons at the amino acid positions of 3, 66, 133, and 151. In this 
research, we chose to use these various GFP mutants for the incorporation of terphenyl.
In hopes of using an already evolved synthetase and avoiding a lengthy and 
tedious aaRS selection process, previously evolved synthetases were screened for use of 
incorporation of terphenyl into GFP. The synthetases initially screened were chosen 
based on their known 'promiscuity' (See Chapter 1) or their ability to incorporate UAAs 
that are structurally similar to the terphenyl moiety.
Incorporation studies involved the co-transformation of BL21(DE3) E. coli cells 
with a pET-GFP-TAG-151 plasmid and a plasmid encoding a known synthetase. A single 
colony was then selected and grown for expression in the presence of 100 mM 4, or in 
the absence of the amino acid as a control. Following expression, the fluorescence of the 
GFP was measured using a plate reader (Figure 2.2).
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Figure 2.2: Plate reader data of initial screened synthetases pCNF, pBzF, and NapA. Tests 
were performed to measure fluorescence of purified protein with and without the 
incorporated UAA. The presence of fluorescence from the GFP shows that the protein is 
functional, therefore indicating successful incorporation of terphenyl.
As seen in Figure 2.2, cultures containing the pCNF and NapA aaRS showed 
differential fluorescence activity between the + UAA and -UAA expressions. The pCNF 
and NapA synthetases were evolved to specify a unique structural group. (Figure 2.3)
Figure 2.3: a) The pCNF synthetase was evolved to recognize a phenylalanine amino acid 
containing a cyano moiety, but displays a level of promiscuity for numerous other UAAs. 
b) NapA was evolved to recognize an alanine containing a naphthalene functionality. The 
structural similarity between this structure and the terphenyl plays a key role in the 
incorporation of the terphenyl into the protein.
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Research has shown that the pCNF synthetase system displays a degree of 
promiscuity and is capable of recognizing multiple UAAs,21 making this an ideal synthetase 
for use with terphenyl. The NapA synthetase was evolved to recognize naphthalene 
structures, which are structurally similar to terphenyl, also making this system ideal for 
use with terphenyl. To further confirm the incorporation of terphenyl, the GFP was 
purified using a His- Ni-NTA spin column and analyzed by gel electrophoresis. (Figure 2.4)
Lane 1 2 3 4 5 6
aaR S L WT pCNF pCNF NapA NapA
UAA 4 + - +
Figure 2.4: SDS-PAGE of GFP expression with cultures containing the terphenyl UAA. 
Lanes 3 and 4 confirm the presence of terphenyl using the pCNF aaRS due to the strong 
band presence in lane 4 and lack of, or weak presence, in lane 3. Similarly, the band in 
lane 6 indicates protein presence when using the NapA aaRS and expressing with 
terphenyl.
Gratifyingly, the incorporation of terphenyl was confirmed in both the pCNF and 
NapA synthetases. This incorporation was performed with the GFP-TAG-151 plasmid;
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however, it would be advantageous to incorporate the probe at multiple residues to 
investigate the effect of different chemical environments on fluorescent properties. 
Thus, we set forth to incorporate 4 at different positions on GFP to validate its utility.
C. Using GFP Mutants fo r  Fluorescence Studies
As previously mentiones, GFP plasmids containing the TAG codon at numerous 
sites within GFP have already been engineered. These positions include 3, 66, 133, and 
151. Incorporating 4 at these different positions allows for further research of the effects 
of this UAA based on its structural location within the protein. The residues used for site- 
specific incorporation can be seen in Figure 2.5.
Figure 2.5: Crystal structure of GFP showing the different sites available for site-specific 
incorporation of terphenyl. Significantly, position 66 is located within the protein at the 
site of GFP's natural chromophore. Positions 3, 151, and 133 are located on the outer 
surface of the protein.
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Each of these residues has a unique location in the protein that is beneficial when  
studying effects of an incorporated fluorescent probe. Position 66 is found on the inside 
of the protein, and is a key residue in GFP's natural fluorophore. Residue 3 is found at 
the N-terminus as part of a non-structured loop, and residue 133 is found opposite 
residue 3 in a segment harboring a structured loop. Position 151 is found on the end of a 
(3-sheet that comprises the (3-barrel of the protein, and is therefore the residue that is 
most rigid. By incorporating 4 at each of these residues and analyzing the fluorescence 
via excitation at 395 nm, dramatic effects can be seen that offer insight regarding the  
overall effects of this UAA on GFP. (Figure 2.6)
GFP151
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Figure 2.6: Emission spectra of GFP mutants containing 4 at each described residue. 
Protein was excited at 395 nm.
19
Overall, compared to the WT GFP spectrum (in green), each mutant containing the 
terphenyl displays a slight red shift to a higher wavelength. The 455 nm and 512 nm 
emissions seen in the WT protein, respectively, correspond to the protonated and 
deprotonated forms of tyrosine residue 66 located within the core fluorophore, and can 
be seen to be impacted significantly in some of these mutants. When terphenyl is inserted 
at residue 66, the 512 nm emission completely disappears in favor of the 455 nm 
emission, which is logical due to the loss of the hydroxyl group and its acid/base 
properties within the fluorophore. Inserted at residue 151, the terphenyl seems to have 
no effect on either the 512 nm or 455 nm emissions relative to WT, as position 151 is 
more rigid than the others, and therefore is not significantly altered due to this alteration. 
When the terphenyl is located at the more flexible positions 3 and 133, the 455 nm 
emission is more favored than the 512 nm emission, opposite of what is typically favored 
in WT. This indicates that inserting terphenyl at these positions causes an overall 
structural change in the protein, as well as change of the resting protonation state of the 
tyrosine located at position 66.
Furthermore, by exciting each mutant at 300 nm, we can also detect the terphenyl 
fluorescence within the GFP. (Figure 2.7)
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Figure 2.7: Fluorescence emissions spectra of each m utant GFP. Protein was excited at 
300 nm.
According to  literature, terphenyl displays an emission maximum at ~342 nm 
when excited at 300 nm .12 As shown in Figure 2.7, W T GFP has only slight natural 
emission when excited at 300 nm. However, overall we can see that terphenyl alters the  
Xmax of the emission when inserted at each position. The new emission is shown to be 
broader and more intense. Specifically, when inserted at position 66, the emission shifts 
significantly, becomes much broader, and is double the intensity of the original WT.
Overall, by exciting the protein at both 300 nm and 395 nm, we are able to view  
altered fluorescence behavior of GFP due to the site-specific insertion of terphenyl. 
Hence, insertion provides a highly selective mechanism for tuning GFP fluorescence.
In conclusion, this research was able to incorporate a terphenyl moiety into GFP 
via use of an orthogonal tRNA and aminoacyl-tRNA synthetase system. This afforded
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complete genetic and site-specific incorporation of the terphenyl UAA, which had not 
been previously accomplished. Furthermore, upon UAA incorporation, this research 
documented that terphenyl was an environmentally sensitive fluorescent probe in GFP, 
allowing for a better understanding of photo-physical behavior of GFP upon site-specific 
alteration.
III. Materials and Methods
General. Solvents and reagents were obtained from either Sigma-Aldrich or Fisher 
Scientific and used without further purification, unless noted. Reactions were conducted 
under ambient atmosphere with non-distilled solvents. NMR data was acquired on a 
Varian Gemini 400 MHz. Fluorescence data was measured using a PerkinElmer LS 55 
Luminescence Spectrometer. All GFP proteins were purified according to manufacturer's 
protocols using a Qiagen Ni-NTA Quik Spin Kit.
Synthesis:
2. N-(fe/t-butoxycarbonyl)-4-iodo-L-phenylalanine methyl ester. To a solution of Boc- 
Phe(4-l)-OH (500 mg, 1.3 mmol) in 10 mL DMF was slowly added NaHCOs (323 mg, 3.8 
mmol, 3 equiv.). Methyl iodide (97 uL, 1.9 mmol, 1.5 equiv.) was then added to the 
mixture and the reaction was allowed to stir under argon for 24 hours at 60 °C. The cooled 
reaction mixture was then extracted and washed with water and EtOAc (3 x 20 mL). The 
organic layer was dried with MgSC>4 and the solvent was removed in vacuo to leave a 
yellow oily solid. This product was then purified via silica gel chromatography with a 
gradient elution hexanes:EtOAc (3:1 1:1). N-(fe/t-butoxycarbonyl)-4-iodo-L-
phenylalanine methyl ester was obtained as a white solid (466 mg, 90%).
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4. 4-biphenyl-L-phenylalanine. To a mixture containing N-(te/t-butoxycarbonyl)-4-iodo- 
L-phenylalanine methyl ester (200 mg, 0.24 mmol) and 4-biphenylboronic acid (202 mg,
1.02 mmol) in 1:1 THF:Toluene (24 mL) was added a solution of Na2 C0 3  (108 mg, 1.02 
mmol) in water (10 mL). The mixture was degassed with a stream of argon and 
Pd(PPh3)2Cl2 (15 mg, 0.02 mmol) was added slowly to the reaction. The reaction was then 
stirred vigorously at 80 °C for 16 hours. The cooled reaction was then extracted using 
EtOAc and water (3 x 20 mL each) and the organic layer was dried with MgS0 4 . Solvent 
was removed in vacuo. The crude product was then purified on a silica gel column using 
hexanes:EtOAc (5:1->1:1). To remove the protecting group, a 1:1 LiOH/dioxane solution 
(2 mL) was added to the product on ice and stirred for 2 hours at room temperature. The 
dioxane was removed in vacuo. The aqueous solution was cooled on ice and 6 M HCI was 
added until a pH of 4 was achieved. The solution was extracted and washed with water 
and EtOAc and the organic layer was dried with MgS0 4 , and then concentrated in vacuo. 
The yellow oil was resuspended in 50% TFA solution (500 pL TFA/500 pL DCM) on ice and 
allowed to stir at room temperature for 1 hour. The solvent was then removed in vacuo 
and product was obtained as a white solid (208 mg, 99%). *H NMR (400 MHz;CDbOD): 6 
7.20-7.75 (m, 18H), 4.20 (t, J=1.5 Hz, 1H), 3.05-3.35 (m, 2H)
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NMR of protected form of terphenyl:
7 6 S 4 3 2 1 ppm
*H NMR (400 MHz; d-MeOH): 6 7.20-7.75 (m, 18H), 5.05-4.85 (m, 1H), 3.78 (s, 3H), 3.05- 
3.35 (m, 2H), 1.42 (s, 9H).
General GFP Expression. A pET-GFP-TAG variant plasmid (0.5 pL) was co-transformed 
with a pEVOL-pCNF plasmid (0.5 pL) into Escherichia coli BL21(DE3) cells using an 
Eppendorf eporator electorporator. The cells were then plated and grown on LB agar in 
the presence of chloramphenicol (34 mg/mL) and ampicillin (50 mg/mL) at 37 °C 
overnight. One colony was then used to inoculate LB media (4 mL) containing both 
ampicillin and chloramphenicol. The culture was incubated at 37 °C overnight and used 
to inoculate an expression culture (10 mL LB media, 50 mg/mL Amp, 34 mg/mL Chlor) at 
an OD6 0 0  0.1. The cultures were incubated at 37 °C to an OD6 0 0  between 0.6 and 0.8 at
24
600 nm, and protein expression was induced by addition of the UAA (100 pL, 100 mM) 
and 20 % arabinose (10 pL) and 0.8 mM isopropyl (3-D-l-thiogalactopyranoside (IPTG; 10 
pL). The cultures were allowed to shake at 30 °C for 16-20 h then centrifuged at 5,000 
rpm for 10 minutes and stored at -80 °C for 3 hours. The cell pellet was re-suspended 
using 500 pL of Bugbuster (Novagen) containing lysozyme, and incubated at 37 °C for 20 
minutes. The solution was transferred to an Eppendorf tube and centrifuged at 15,000 
rpm for 10 minutes, then the supernatant was poured into an equilibrated His- pur Ni- 
NTA spin (Qiagen) column of nickel resin (200 pL) and GFP was purified according to 
manufacturer's protocol. Purified GFP was analyzed by SDS-PAGE (BioRad 10% precast 
gels, 150V, 1.5h), and employed without further purification.
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Chapter 3- Toward Incorporation of a Photocaged Selenocysteine
I. Introduction
A. Selenocysteine os the 21st Amino Acid
Traditionally speaking, there are 20 known amino acids; however, the selenium 
containing amino acid Selenocysteine (Sec, U) is often referred to as the 21st.4 (Figure 3.1) 
Research on this unique amino acid has picked up in the last decade due to findings that 
suggest it may be employed in cancer prevention.1 Selenium derivatives have been used 
as successful tumor-suppressant agents in rodents2 and have the potential ability to act 
as chemoprotectors against negative side effects of drugs.3 Moreover, at least 25 
selenoproteins are known in humans, including glutathione peroxidase and thioredoxin 
reducatase. Selenoproteins exhibit important functions in humans, such as control of our 
cells oxidation state, sperm maturation, brain development, and endocrine system 
function.9 Despite all of the current knowledge surrounding this amino acid, many 
biological roles of selenocysteine remain undiscovered. Consequently, due to the 
significant biological relevance of this amino acid, continued research of selenocysteine 
and its derivatives are of high importance in the fields of biochemistry and medicinal 
chemistry.
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Figure 3.1: Structure of Selenocysteine.
Selenocysteine exhibits the three main characteristics common to the twenty 
canonical amino acids: it is inserted during translation of mRNA, has its own codon (UGA), 
and has its own unique tRNA.5 The UGA codon that recognizes Sec, however, also 
naturally serves as a stop codon. In order to encode the UGA codon to act as a recognition 
element for selenocysteine, a unique structure in an untranslated portion of the mRNA 
called a selenocysteine insertion sequence (SECIS) is required. Unfortunately, this 
machinery varies in prokaryotic cells and eukaryotic cells, making incorporation and 
recognition of selenocysteine a difficult task.6 One method for overcoming this barrier is 
using solid phase peptide synthesis in combination with native chemical ligation. Early 
selenocysteine research often involved the use of an Fmoc and Mob group as the amino 
acid protection functionality (forming a Fmoc-Sec(Mob)-OH protected AA). This provided 
several disadvantages, however. The use of Mob often caused racemization, and 
deprotection of the Fmoc group included the use of piperdine-which was shown to cause 
deselenation of the amino acid, forming an alanine. To alleviate this, focus of 
selenocysteine protection shifted to the use of Boc/Benzyl groups for protection.5 Using 
the Boc group allows for pH controlled deprotection, utilizing a more acidic/neutral 
environment for deprotection and cleavage protocols.8 A benzyl functionality is used
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alongside of a Boc group as a protection group for the selenium ion. Another reported 
method to incorporate selenocysteine into proteins involves chemically converting serine 
to selenocysteine; however, these conversions are often cumbersome and do not achieve 
site-specificity.10
To alleviate these issues, we propose incorporating a selenocysteine UAA into 
proteins using site-specific genetic insertion. This has been attempted previously, but the 
inherent reactivity of selenocysteine has prevented successful evolution of the 
aminoacyl-tRNA synthetase required to charge the tRNA. In order to protect the reactive 
selenium, as well as create an external mechanism to restore its function in a spatial and 
temporal fashion, we aim to first protect the reactive selenium with a photolabile 
protecting group- specifically, an o-nitrobenzyl caging group. By attaching this moiety and 
inserting the caged UAA into a protein, we hope to exploit the unique properties 
associated with photocaging amino acids, while at the same time affording potential 
regulation and enhancement using selenocysteine as a therapeutic agent.
B. Caged UAAs
Proteins have a wide range of biological functions and utilize many mechanisms 
to regulate these functions. In order to further study these functions, it is beneficial to 
externally alter or knock-out a protein function to observe the phenotypic effects. 
Moreover, a non-endogenous mechanism to turn protein function on and off could
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possess a high degree of therapeutic value. A highly effective tool for regulation of 
biological process involves covalently attaching a photolabile group to small organic 
molecules or amino acids.11 There are numerous methods and groups used to modify or 
"cage" small molecules for photoregulation. One popular method involves attachment of 
a nitrobenzyl group to a biologically active agent, allowing the researcher specific control 
of the overall function. When the caging group is attached, function will be abbrogated; 
however, when irradiated with non-cytotoxic UV light, the caging group is removed and 
function is restored.12 (Figure 3.2)
Figure 3.2: When a protein is expressed using a chemically caged amino acid, the protein 
is rendered inactive. Once exposed to light, however, the caging group detaches, 
restoring protein activity
Due to the significant biological value of selenocysteine, we propose attaching a 
nitrobenzyl group to this amino acid (Figure 3.3) in order to both protect the reactive 
selenium during incorporation as well as further control selenoprotein function once 
incorporated.
UV Light
Caged protein, inactive Active Protein Caging Group
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Figure 3.3: Structure of caged Selenocysteine.
II. Synthesis of Caged Selenocysteine
Caged selenocysteine was synthesized based on a previous literature precedent.4 
The synthesis was initiated from the reaction of L-Selenocysteine with a reducing agent, 
followed by nitrobenzyl-bromide (Scheme 3.1).
Scheme 3.1.
1) 0.5M NaOH/EtOH
NaBH4
2) 2M NaOH
n o 2
3) HCI
Upon completion of the reaction, solvent was removed from the product in vacuo 
and the product was purified on a silica column using 10:1 DCM:MeOH, then analyzed via 
1H NMR. The caged selenocysteine was obtained as a yellow solid in good purity (81%). 
Moving forward, the focus of this research will shift to incorporating this caged UAA into 
a model protein via the use of a promiscuous aaRS . Attempts will be made using a wide
array of known synthetases in hopes of finding an already established aaRS that would 
recognize the selenocysteine UAA to charge the corresponding orthogonal tRNA.
III. Materials and Methods
General. Solvents and reagents were obtained from either Sigma-Aldrich or Fisher 
Scientific and used without further purification, unless noted. Reactions were conducted 
under ambient atmosphere with non-distilled solvents. NMR data was acquired on a 
Varian Gemini 400 MHz.
Synthesis of Caged-Selenocysteine
L-Selenocysteine (20 mg, 0.06 mmol) was dissolved in 320 jlxL 0.5M NaOH and 80 jllL EtOH. 
Starting material was cooled to 0 °C and sodium borohydride (16 mg, 0.6 mmol) was 
added to the reaction while stirring. Over the course of addition, the reaction turned from 
yellow to clear. Reaction was then allowed to reach room temperature, then cooled again 
to 0°C. Upon cooling, 2M NaOH (160 p i) was added to reaction along with nitrobenzyl- 
bromide (52 mg, 0.24 mmol). The reaction was allowed to stir at room temperature for 
an additional 3 hours. Upon completion, the reaction was quenched with HCI to a pH of 
6.5. Solvent was then removed in vacuo and the product was purified via silica gel column 
chromatography (DCM:MeOH 10:1) to afford a yellow solid (0.015 g, 0.048 mmol, 81%). 
XH NMR (400 MHz; D20): 6 7.42-8.05 (m, 8H), 4.15 (s, 2H), 3.85 (t, J=7.0 Hz, 2H), 3.0 (m, 
2H).
33
References
1. Thompson, H. J., Wilson, A., Lu, J., Singh, M., Jiang, C., Upadyaya, P., Bayoumy, E., Ip, 
C.; Corcinogenosis. 1994 ,15, 183-186.
2. Baldew, G.S., Van de Hamer, C.J., Los, G., Vermeulen, N.P., De Goeij, J.J.; Cancer 
Research. 1989, 49, 3020-23.
3. Vadhanavikit, S., Ip, C., Ganther, H.E.; Xenobiotica, 1993, 23, 731-745.
4. Andreadou, I., Menge, W .M., Commandeur, J. N., Worthington, E. A., Vermuelen, N. 
P.; Journal o f Medicinal Chemistry. 1996, 39, 2040-2046.
5. Schroll, A.L., Hondal, R.J., Flemer Jr., S.; Journal o f Peptide Science. 2012 ,1 8 ,155-162.
6. Hondal, R.J., Nilsson, B.L., Raines, R.T.; Journal o f the American Chemical Society. 2001, 
123, 5140-5141.
7. Besse D, Moroder L. Journal o f Peptide Science. 1997; 3, 442-453.
8. Muttenthaler M, Alewood PF. Journal o f Peptide Science. 2008; 14: 1223-1239.
9. Wessjohann LA, Schneider A. Chemical Biodiversity. 2008; 5, 375-388.
10. Rakauskaite, R.,Urbanaviciute, G., Ruksenaite, A., Liutkeviciute, Z., Juskenas, 
R., Masevicius, V., Saulius Klimasauskas, S.; Chemical Communications. 2015.
11. Riggsbee, C.W., Deiters, A., Trends in Biotechnology. 2010; 28. 468-475.
12. Adams, S.R., Tsien, R.Y., Annual Review o f Physiology. 1993; 55. 755-784.
34
Chapter 4-Introduction to Glaser Hay-Coupling and Solid-Support 
Synthesis
I. The Polyyne Scaffold
Polyynes are molecules containing two or more conjugated acetylene units. 
Because of this high degree of Tt-system conjugation, they are often unstable compounds, 
but are rich in biological and optical properties.13 For years, these compounds have been 
isolated from a wide variety of natural sources such as fungi, coral, plants, and bacteria 
cultures.2 They are known to display numerous biological activities including: 
antibacterial, antifungal, anticancer, and anti-HIV properties.2 This conjugated acetylenic 
scaffold can also be observed as a core structure in polymers and other supramolecular 
materials. The structure gives polymers a versatile linear geometry, which in turn results 
in molecules with unique optical properties. Siemsen et al. reported that polymers 
containing polyyne structures and transition metals lead to a unique array of 
photovoltaic, nonlinear optics, and luminescence properties as well as distinctive crystal 
structures.1
Classically, polyynes are isolated from a wide variety of natural sources. Over one 
thousand compounds containing these cores have been isolated and shown to exhibit 
biological activity.3 (Figure 4.1)
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Figure 4.1: Examples of naturally occurring polyyne structures and their uses as natural 
products.2
Many biologically active polyyne molecules have the potential to be prepared in 
the lab setting. The following research discusses the discovery and optimization of a 
methodology to efficiently synthesize polyyne molecules in good yield and with minimal 
steps and purification. It was hypothesized that by utilizing a solid-support, numerous 
biologically active polyyne molecules could be generated easily and quickly. The described 
methodology builds on the established Glaser reaction from 1869, and focuses on 
applying a solid-support system to overcome issues associated with previously described 
Glaser-Hay reactions. The Glaser-Hay reaction was chosen for testing on the solid-support 
system due to having a high tolerance of various alkyne functional groups. Moreover, the 
vast amount of commercially available acetylenic starting material makes using this 
reaction optimal for combinatorial chemistry, with the potential for creating a diverse 
library of polyyne compounds.
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II. The Standard Glaser Coupling and Further Advancements
In 1869, synthesis of polyyne core structures was developed by Glaser utilizing the 
oxidative dimerization of copper (I) phenylacetylide upon exposure to air to yield the 
conjugated polyyne (Scheme 4 .1).4
Scheme 4.1.
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To further enhance the scope of the Glaser reaction, others have established 
variant reactions.5 For example, a new milestone utilizing oxidative acetylenic coupling 
was discovered by Eglinton and Galbraith in 1956. This protocol coupled acetylenic units 
by using a copper salt oxidation in methanolic pyridine to provide a homocoupled 
polyyne.12 Further, a reaction introduced in 1957, the Cadiot-Chodkiewicz reaction, began 
to pave the way for synthesis of asymmetrical polyynes. The Cadiot-Chodkiewicz reaction 
is a cross-coupling reaction utilizing a terminal alkyne/haloalkyne partner and a copper 
salt/amine base catalyst to provide the desired heterodimer (Scheme 4.2).6
Scheme 4.2
CuCI. NH.OH 
EINH. MeOH N.
R ~  + Br “ H R:, ----------------------------- ►  R—= —
The variant Glaser reaction that provides the basis for this research was
established by Hay in 1962. Hay employed catalytic amounts of copper (I) chloride in the
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presence of tetramethylenediamine (TMEDA) and oxygen which led to a drastic decrease 
in reaction time. The resulting Glaser-Hay reaction produced symmetric polyyne 
molecules in an efficient fashion and afforded higher yields than the standard Glaser 
reaction (Scheme 4.3).7
Scheme 4.3
CuCI. TMEDA
R—=  » 0 !> O: R —= — = — R
III. Current Glaser-Hay Coupling Reaction Limitations
The Glaser-Hay reaction is a rapid and efficient method to produce symmetrical 
polyynes from a common terminal alkyne. However, this reaction does not display 
chemoselectivity when performed with two different terminal alkyne reactants. Using the 
standard Glaser-Hay conditions while reacting two terminal alkynes yields three different 
products: two homodimers and a heterodimer (Scheme 4.4). The formation of three 
products results in tedious further purification and a decreased yield (statistically a 33% 
yield at best) of the desired heterocoupled product. Additionally, since many of the 
natural products and biologically active compounds are heterodimers, this reaction is not 
synthetically useful in their preparation.
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Scheme 4.4
Solvent
Various researchers have employed a solution phase Glaser-Hay reaction using 
copper acetate or nickel chloride as the catalyst system to produce asymmetrical 
polyynes. These methodologies are limited to terminal alkyne precursors that will create 
a homocoupled product that is able to be isolated from the heterocoupled product, which 
requires extra purification steps and therefore the desired asymmetrical product is only 
obtained in minimal yield.8
IV. Solid Supported Synthesis: Overcoming the standard limitations
Solid-supported synthesis has found a widespread use in organic chemistry, 
providing an efficient means to produce an expansive number of compounds. Solid 
supports contain an insoluble polymeric backbone, allowing the attached product to be 
isolated from the solution phase and affording products in high purity and yield.14 To date, 
there is a wide array of solid support systems available, including those with amino,
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carboxy, halogen, and hydroxyl functionalities.15 The type of resin for solid-supported 
synthesis is chosen based on the desired reaction and the reagents used. Overall, benefits 
of using solid-supported synthesis include: pseudo-high dilution conditions, the ability to 
easily wash away excess reagents, and structural rigidity.14 Therefore, in order to obtain 
a desired asymmetrical polyyne and address the chemoselectivity issues associated with 
the Glaser-Hay reaction, we propose immobilizing one of the terminal alkynes on a 
polystyrene solid support.9 Once immobilized, the terminal alkyne can be reacted with a 
different alkyne using the copper catalyst/TMEDA system associated with the standard 
Glaser-Hay reaction. The solid-support immobilization allows for control over reaction 
products by allowing the researcher to quickly wash away excess homocoupled product 
or terminal alkyne reactant while leaving the desired asymmetrical molecule attached to 
the solid-support. Immobilization of the alkyne also prevents its homodimerization, 
resulting in pure heterocoupled product upon cleavage from the resin.
Other reactions utilizing a solid-support system have previously been shown to 
achieve chemoselectivity. One such reaction is the Cadiot-Chodkiewicz reaction which 
utilizes a terminal alkyne and a haloakyne to produce an asymmetrical polyyne.6 By 
immobilizing a haloalkyne on a solid-support and reacting it with a terminal alkyne, 
researchers were able to eliminate any homodimer formed by the standard reaction.11
Although the solid-supported Cadiot-Chodkiewicz reaction was successful, that 
reaction variant already exhibits a degree of chemoselectivity. Thus, the investigation of 
a solid-support system for the Glaser-Hay reaction seemed even more advantageous in
40
that it was a reaction that would not require the synthesis of a haloalkyne precursor, and 
also demonstrates shorter reaction times and requires fewer post-reaction workup steps, 
allowing for the efficient synthesis of numerous polyynes.
Even more relevant, Liao et al. described first attempts at Glaser-Hay reactions 
using a solid-support. Their research, however, was focused on creating a high yield of a 
specific homocoupled product.10 Liao et al. utilized the benefits provided by solid-support 
as well as a AgOTs-CuCl2 -TMEDA catalyst system in order to dimerize aliphatic acetylenes 
(Figure 4.2).10 The silver (or silver tosylate) in their catalyst system facilitated the coupling, 
and their work was of vast importance due to the fact that the Glaser-Hay reaction had 
not been previously performed on solid-support. Ultimately, this group was able to utilize 
solid-support and their unique AgOTs-CuCh-TMEDA catalyst system to efficiently produce 
a small library of homocoupled bis-benzo[b]furan-linked 1,3-diynes.
Figure 4.2: Liao et al.'s reaction scheme including their unique catalyst system. This group 
proposed that Ag along with the typical copper catalyst system would further facilitate 
the coupling reaction, and result in the quick formation of a pure homocoupled product.10
AgOTs, CuCfe 
TMEDA
MeO 0  Rj
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For this research, we hypothesized that a new methodology employing a solid- 
support to the Glaser-Hay reaction could be created and optimized to afford asymmetric 
polyynes in high purity and yield. The developed methodology would alleviate the 
chemoselectivity issues often associated with the standard Glaser-Hay reaction and 
eliminate the need for tedious post-reaction purification. The solid-supported Glaser-Hay 
methodology aims to provide an easy synthetic route to the creation of a diverse polyyne 
library, benefitting the fields of combinatorial, organic, and medicinal chemistry.
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Chapter 5- Solid-Supported Glaser-Hay Couplings 
I. Introduction
To alleviate the associated chemoselectivity issues of the Glaser-Hay reaction, we 
present the development and optimization of solid-supported Glaser-Hay couplings. This 
novel methodology allows for the rapid preparation of asymmetric polyynes in high purity 
and yield. Furthermore, fluorescence spectroscopy is used to expose the unique optical 
properties of these molecules and offer further characterization. Overall, this 
methodology will benefit the fields of combinatorial, organic, and medicinal chemistry, 
and provide a quick route to asymmetrical polyynes.
II. Results and Discussion
A. Establishment o f Reaction Conditions
Due to the chemoselectivity problems associated with the Glaser-Hay reaction, 
this reaction was promising for optimization on a solid-supported resin. Also, as it is a 
widely utilized synthetic reaction, there were a wide array of established reaction 
conditions in the literature.1 Reaction conditions were investigated using different solvent 
and catalyst systems in order to optimize this reaction on a solid support. As a proof-of- 
concept, phenylacetylene was used for a standard homocoupling Glaser-Hay reaction in 
solution. Based on literature searches, possible catalyst systems included CuCI/TMEDA, 
Cul/TMEDA, and Cul/DIEPA/N-bromosuccinimide.1 Standard reaction conditions (12
hours at room temperature) were carried out with phenylacetylene in solution in order
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to test each of these systems. The CuCI/TMEDA system surprisingly did not produce any 
product, indicating a possible solubility or reactivity problem within this reaction. 
Furthermore, the Cul/DIEPA/N-bromosuccimide system only produced trace amounts of 
product, possibly due to negative interactions with the polystyrene core of the resin. 
Gratifyingly, the Cul/TMEDA was found to produce a high yield of homocoupled 
phenylacetylene, indicating that this would be an ideal catalyst system to use for the solid- 
supported Glaser-Hay reactions.
B. Resin Optimization
Initially, three different types of polystyrene resins were investigated: carboxy, 
trityl chloride, and bromo derivatized supports. Overall, the trityl chloride resin was 
chosen based on having high reproducibility with alkyne loading and mild alkyne 
immobilization and cleaving conditions. Propargyl alcohol (10 equiv.) was first chosen for 
immobilization on the resin, and was reacted at room temperature for 16 hours with the 
trityl chloride resin and triethylamine (10 equiv.). This afforded a propargyl alcohol loaded 
resin that could then be employed in Glaser-Hay reactions. Phenylacetlyene was the 
terminal alkyne used to optimize coupling conditions based on the ability to easily 
observe the heterodimeric products via XH NMR and TLC. Solvents, temperatures, and the 
loading of the resin were all varied to determine optimal conditions.
Several solvents were examined, including toluene, THF, DCM, and acetonitrile. 
Alkynes were reacted in each solvent for 12 hours at room temperature, and the yield of
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product was determined following resin cleavage. THF was chosen due to the fact that it 
reproducibly afforded the highest yields, and all other solvents resulted in substantial 
amounts of unreacted starting material. To further optimize reaction conditions, reaction 
temperature was then varied, with 30 °C, 60 °C, and 80 °C all tested. Reactions conducted 
at 30 °C did not provide sufficient heat for the reaction to progress, and afforded no yield 
of product. The high temperature of 80 °C was found to drive the reaction to completion; 
however, product yields were low, potentially due to the high temperature leading to 
resin degradation. When performed at 60 °C, yields were found to be favorable, and 
therefore this temperature was selected as optimal for this reaction.
Additionally, it was demonstrated that resin loading conditions played a critical 
role in optimization of the solid supported reaction. When a propargyl alcohol derivatized 
resin was reacted with phenylacetylene for 12 hours at 60 °C, homodimerization of the 
immobilized propargyl alcohol was discovered. This formation resulted in a lower reaction 
yield, and failed to eliminate homocoupled product, which was the overall goal of the 
immobilization. Also, further purification was then needed to eliminate the undesired 
product. Therefore, further optimization was necessary in order to obtain asymmetrical 
polyynes in good yield and without the formation of the undesired homodimer.
To alleviate this undesired coupling product, the initial loading of propargyl 
alcohol onto the resin was investigated. Due to the formation of propargyl alcohol 
homodimer, it was believed that decreasing the loading of propargyl alcohol onto the 
resin would reduce immobilization proximity and prevent homodimerization. Initially,
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propargyl alcohol was loaded onto the polystyrene resin in 10 equivalents with TEA (10 
equiv.), affording a resin loading value of 1 mmol/g. This had resulted in maximum loading 
of the starting material and ultimately led to homodimerization issues. To decrease 
loading values, amount of starting material and immobilization reaction time were 
lowered and loading was assessed.
Resins were then immobilized using a range of conditions. By using a trityl chloride 
resin with 10 equiv. of propargyl alcohol and 10 equiv. of TEA and reacting at 40 °C for 16 
hour a higher loaded resin of ~1.8 mmol/g was achieved. Another reaction using same 
amounts of reagents at the same temperature, but only a 2  hour reaction time was also 
set up and afforded a ~1.0 mmol/g medium loaded resin. Finally, the amount of starting 
propargyl alcohol was decreased to produce a low loaded resin of ~0.6 mmol/g (Scheme 
5.1). Loading conditions could be quantitated via cleavage of the immobilized resin with 
2% trifluoroacetic acid, and analysis of resin loadings based on mass recovery and GC/MS 
values found for propargyl alcohol. 2
Scheme 5.1
HO
\ —
The derivatized resins were then assessed using the previously optimized reaction 
conditions for the solid-supported Glaser-Hay coupling (60 °C for 16 hr.). The loading
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proved to have significant effect on the product formation, as the resins loaded above 0.7 
mmol/g were found to produce the undesired homodimer. Satisfyingly, the lower loaded 
resin eliminated the homodimer formation, and could still be used to efficiently produce 
the desired asymmetrical polyynes.
C. Preparation o f a Diverse Diyne Library
With solid-supported Glaser-Hay reaction conditions optimized, the methodology 
could be applied to a plethora of terminal alkynes in order to afford a diverse diyne library. 
Propargyl alcohol and 4-ethynyl benzyl alcohol were immobilized on the trityl choride 
resin to afford resin loadings of 0 . 6  mmol/g.
Optimization experiments demonstrated that ideal conditions to maximize both 
yield and purity were as follows: reacting for 16 hours at 60 °C in tetrahydrofuran with a 
Cul/TMEDA catalyst system. (Scheme 5.2 and 5.3) Upon completion, the reactions were 
filtered and washed with alternating rinses of DCM and MeOH. These washes were 
employed in order to remove the excess unreacted starting material and any homodimer 
that resulted from the undesired reaction of the soluble alkyne with itself. The filtered 
and washed resin was then dried and cleaved with 2% trifluoroacetic acid. All solvent was 
easily removed in vacuo, and the desired product was analyzed via 1H NMR and GC/MS.
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Scheme 5.2
10 eqiiv.
1) 0.5 equiv. Cul
0.5 equiv. TMEDA
THF 
60 °C 16 h
2) 2%TFA  
rt, 1 h
Scheme 5.3
30
We next employed these conditions with a variety of terminal alkynes. Aromatic 
rings, silyl groups, amines, alcohols, and alkyl chains were all assessed in the solid- 
supported Glaser-Hay reactions to provide a diverse set of diyne products. (Tables 5.1 
and 5.2)
-  *
10 equiv.
1) 0.5 equiv. Cul 
0.5 equiv. TMEDA
THF 
60 °C 16 h
2) 2% TFA
rt. 1 h
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Table 5.1: Diynes synthesized using immobilized propargyl alcohol resin.
Alkyne Product % Yield
50
Table 5.2: Diynes synthesized using 4-ethynyl benzyl alcohol immobilized resin.
Alkyne Product % Yield
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During the analysis of different terminal alkynes, it was discovered that the 
alkynes containing nucleophilic species, such as amine, benzyl alcohol, thiophene, and 
pyridine, often resulted in lower reaction yields. These nucleophilic species could 
potentially interact with the copper catalyst system, therefore interfering in its ability to 
yield diyne and lowering the overall yield. It was elucidated that the lower yields due to 
nucleophilic reactants could be avoided by protecting the nucleophilic site with a trityl 
group. (Affording Product 7) Moreover, the protecting group can be easily removed with 
the 2% TFA cleavage step obviating the necessity for an additional deprotection.
To further enhance the scope of this methodology, the resin was also loaded with 
propargyl amine. (Scheme 5.4). The propargyl amine resin was shown to undergo the 
same reactions with terminal alkynes under identical reaction conditions. Overall, this 
allowed for the preparation of the same scaffold generated from the alcohol loaded 
resins, but now with the amine functionality present. (Table 5.3)
Scheme 5.4
1) 0.5 equiv. Cul
0.5 equiv. TMEDA 
THF  
60 °C 16 h
-NH
R
21
2) 2% TFA
rt, 1 h
10 equiv.
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Table 5.3: Diynes synthesized using propargyl amine immobilized resin.
Alkyne Product % Yield
Overall, this work demonstrates that the solid-supported Glaser-Hay methodology 
can be employed with a diverse set of terminal alkynes in order to afford a variety of 
asymmetrical diynes, increasing yields and solving the standard chemoselectivity issues 
associated with the Glaser-Hay reaction. These reactions required little reaction work-up 
or purification and resulted in good yields.
D. Extending the Technology Towards the Synthesis o f Polyynes
With the solid-supported Glaser-Hay reaction optimized and diyne library 
prepared, this research transitioned to extend the carbon backbone of the acetylenic 
scaffold and create a similar library of polyyne molecules including triynes, tetraynes, and 
pentaynes. By doing so, this methodology could be used to synthesize a wider array of 
biologically relevant molecules. Furthermore, upon extended conjugation these 
molecules have potential as highly conductive molecular wires.
To begin this extended methodology, we are able to utilize molecules made in the 
initial asymmetrical diyne libraries. The diyne library includes three asymmetrical diyne 
molecules that involved reacting the immobilized terminal alkyne with 
trimethylsilylacetylene (TMS acetylene). Fortuitously, these molecules can undergo a silyl 
deprotection by reacting with the nucleophilic fluorine species in tetra-n-butylammonium  
fluoride (TBAF). The TMS cleavage regenerates a terminal alkyne that can be further 
reacted in the Glaser-Hay coupling with an additional terminal alkyne or can further be 
extended by another addition and cleavage of TMS. (Scheme 5.5)
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Scheme 5.5
TMS-
Q  ( — )  H *  TMS = =  --------------------► O  ( — )  —
capping
cleavage
Desilylation in order to prepare polyynes had been previously reported by Heuft 
et. al. Here, a copper catalyst system was also utilized, and addition and cleavage of TMS 
enabled the researchers to create symmetrical polyynes. 3 By using this methodology and 
applying it to the optimized solid-supported Glaser-Hay reaction, the previously prepared 
asymmetrical diyne library could be further extended and diversified.
E. Preparation o f a Diverse Polyyne Library
To prepare a polyyne library, the trityl-chloride polystyrene resin was loaded as
previously described with either propargyl alcohol or 4-ethynyl benzyl alcohol. These
were chosen due to previous success producing diynes in high yield using a solid support.
Loaded resin was reacted under optimized solid-supported Glaser-Hay conditions with
TMS acetylene. The resin was then washed and dried as described previously. Next, the
resin was subjected to silyl cleavage using a 1 M TBAF solution for 1 hour at room
temperature. Upon cleavage the resin was again washed 5x with DCM and MeOH, and
dried. This afforded a regenerated terminal alkyne on the resin that could either be
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capped with another terminal alkyne or undergo another round of TMS acetylene
addition/cleavage.
Initially, 4-ethynylanisole was chosen for the capping alkyne due to its unique 
NMR signature and easy visualization by TLC via its UV activity. Upon capping, resin was 
cleaved with the 2% TFA solution, resulting in the preparation of a polyyne. The first 
capping produced the triyne of propargyl alcohol and 4-ethynylanisole in good yield (6 8 %) 
and required no further purification. The product was then analyzed via TLC, 1H NMR, and 
GC/MS. This initial product demonstrated that the previously optimized methodology 
could be used to produce a small library of polyyne molecules.
Loaded resin underwent numerous rounds of TMS acetylene coupling/TBAF 
deprotection and terminal alkyne capping to afford a diverse array of tryiynes, tetraynes, 
and pentaynes. 4-Ethynyl benzyl alcohol was also utilized to afford two diverse sets of 
polyyne scaffolds. A variety of terminal alkynes were used for capping and the diverse 
array of synthesized polyynes can be seen in Table 5.4.
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Table 5.4: Polyyne Library
Compound n Producl n Yield
HO
" = ( = U
NH?
HO
V
— * > 0
HO
N =  ( = I >
HO
V
■f— t OH
HO
V
1 18 99%
2 38 68%
3 39 67%
4 40 44%
1 14 45%
2 41 46%
3 42 46%
4 43 48%
1 16 95%
2 44 63%
3 45 63%
4 46 56%
1 15 84%
2 47 53%
3 48 38%
4 49 41%
1 12 99%
2 50 82%
3 51 57%
4 52 49%
1 20 55%
2 53 34%
3 54 30%
4 55 27%
1 35 73%
2 56 56%
3 57 52%
4 58 46%
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Products of the solid-supported reaction needed little (via a quick silica plug) to 
no purification, and were obtained in moderate to good yield. Unfortunately, yet not 
surprisingly, as the number of synthetic steps increased, the yields decreased. However, 
the yields were still rather high given the number of synthetic manipulations. Products 
could be easily characterized via TLC, XH NMR, and GC/MS.
■ O
Figure 5.1: Selected sample XH NMR taken in CDCI3 showing compound purity (Compound 
38).
This extension of the previously reported methodology shows the versatility and 
usefulness of the solid-supported Glaser-Hay reaction. A library of triynes, tetraynes, and 
pentaynes was synthesized efficiently and could be further studied for unique optical 
properties. Additionally, these molecules can be assessed in the future for any biological 
activity they may exhibit.
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F. Fluorescence Properties o f Polyyne Library
Polyynes are known to exhibit unique optical properties due to their substantial 
amount of conjugation. This often results in molecules that may act as molecular wires 
due to their geometric and conducing properties. 4 ,5  Therefore, to elucidate these unique 
properties, the absorbance and fluorescence spectra for these series of molecules were 
next observed and analyzed. Spectra were obtained using a PerkinElmer LS 55 
Luminescence Spectrometer at an excitation wavelength of 330 nm. The fluorescent shifts 
of the different capped alkynes within a series of triynes, tetraynes, or pentaynes was 
studied. The terminal alkynes that contained additional conjugation, such as 
phenylacetylene, exhibited a stronger fluorescence intensity than those containing only 
alkyl sidechains such as hexyne. The difference in intensity and wavelength can be viewed 
throughout each series. (Figures 5.2, 5.3, and 5.4)
Triynes
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Figure 5.2: Fluorescence spectra for triynes, excited at 330 nm. Product solutions were 5 
mM dissolved in DCM.
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Tetrayne
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Figure 5.3: Fluorescence spectra for tetraynes, excited at 330 nm. Product solutions 
w ere 5 m M  dissolved in DCM.
Pentayne
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Figure 5.4: Fluorescence spectra for penatynes, excited at 330 nm. Product solutions 
were 5 m M  dissolved in DCM.
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To further investigate and understand how the shifts correlated to conjugation 
and the extension of the acetylenic scaffold, 4-ethynyl benzyl alcohol was also loaded and 
reacted under standard conditions with ethynylbenzyl alcohol. The fluorescence spectra 
of this series can be seen in (Figure 5.5). This series shows a dramatic blue shift exhibited 
by the pentayne.
350
HO
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Figure 5.5: Fluorescence spectra when excited at 370 nm for 4-ethynyl benzyl alcohol 
reacted with ethynylbenzylanisole. Product solutions were 5 mM dissolved in DCM.
Upon analysis of the fluorescence spectra it was found that there are some 
common themes; however, the overall shifts among the polyynes are difficult to predict. 
As the conjugation due the extended acetylenic scaffold increases, the diyne, triyne, and 
tetrayne displayed a slight red shift from the previous molecule. When the pentayne was
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examined, the spectra did not follow this pattern, and displayed a drastic blue shift from 
the others. It was hypothesized that upon the extension of the highly conjugated core 
these molecules may transition into a polymer-like state. Therefore, the spectra of the 
highly conjugated pentaynes could be dramatically and unpredictably shifted from the 
spectra of the triynes. Literature precedent corroborated that spectral shifts of these 
molecules are hard to predict, but that their unique spectra can still be of use to further 
study and characterize these molecules.6 Through the use of fluorescence spectroscopy, 
we are able to expose these molecules unique optical properties and offer insight into 
further molecule characterization.
III. Materials and Methods
General. Solvents and reagents were obtained from either Sigma-Aldrich or Fisher 
Scientific and used without further purification, unless noted. Tritylchloride resin, 100- 
200 mesh, 1% DVB crosslinking, was purchased from Advanced Chemtech. Reactions 
were conducted under ambient atmosphere with non-distilled solvents. NMR data was 
acquired on a Varian Gemini 400 MHz. GC/MS analysis was conducted on an Agilent 
Technologies 6890N GC system interfaced with a 5973N mass selective detector. An 
Agilent J&W GC capillary column (30 m length, 0.32 mm diameter, 0.25 nm film) was 
employed with a splitless injection (250 °C inlet, 8.8 psi) with an initial 70 °C hold (2 min) 
and ramped for 15 min to 230 °C. Fluorescence data was measured using a PerkinElmer 
LS 55 Luminescence Spectrometer.
Immobilization of Alcohol onto Trityl Chloride Resin in Low Loading Conditions
Trityl chloride resin (200 mg, 0.36 mmol, 1 equiv.) and dichloromethane (5 mL) were
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added to a flame dried vial. The resin was swelled at room temperature with gentle 
stirring for 15 min. Alcohol (25.0 pL, ~1.2 equiv.) was added to the reaction, followed by 
triethylamine (10.0 pL, 0.072 mmol, 0.2 equiv). The mixture was stirred at room 
temperature for 16 h. The resin was transferred to a syringe filter and washed with DCM 
and MeOH (5 alternating rinses with 5 mL each). The resin was swelled in CH2 CI2 and dried 
under vacuum for 45 min before further use. Resin loading was assessed via cleavage of 
15 mg resin in 2% TFA in DCM (200 ttL) at room temperature for 1 hour. After filtration of 
resin, loading was determined both by mass of cleaved product and by GC/MS analysis of 
integrated alcohol peaks from a standard curve and the cleaved resin.
Sample of Glaser Hay Coupling Protocol at 60 °C
Soluble alkyne (0.350 mmol, 10 equiv.) was added to a flame dried vial containing the 
propargyl alcohol derivatized trityl resin (50 mg, 0.035 mmol, 1 equiv.), and 
tetrahydrofuran (0.750 mL). The copper catalyst (10 mg, 0.053 mmol) and 
tetramethylethylenediamine (10 pL, 0.066 mmol) were added to a separate flame-dried 
vial then dissolved in tetrahydrofuran (0.750 mL). The catalyst mixture was then added to 
the resin in one portion and stirred at 60 °C for 16 h. The resin was transferred to a syringe 
filter and washed with DCM and MeOH (5 alternating rinses with 5 mL each). The product 
was then cleaved from the resin by treatment with 2% TFA (DCM, 1 h) and filtered into a 
vial. If necessary, a short silica plug was utilized to remove unreacted starting material 
(1:1 EtOAc/Hex).
Polyyne Extension Protocol
Trimethylsilylacetylene (160 pL, 1.05 mmol, 15 equiv.) was added to a flame dried vial 
containing the alcohol derivatized trityl resin (100 mg, 0.07 mmol, 1 equiv.), and 
tetrahydrofuran (2.0 mL). The copper catalyst (20 mg, 1.06 mmol) and 
tetramethylethylenediamine (20 pL, 0.132 mmol.) were added to a separate flame-dried 
vial then dissolved in tetrahydrofuran (2.0 mL). The catalyst mixture was then added to
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the resin in one portion and stirred at 60 °C for 16 h. The resin was transferred to a syringe 
filter and washed with DCM and MeOH (5 alternating rinses with 5 mL each).
Regeneration of Terminal Alkyne
The TMS group was then cleaved by incubation in 1 M tetra-n-butylammonium fluoride 
trihydrate in DCM (TBAF, 1 mL, 1 h). Then the reaction was again transferred to a syringe 
filter and washed with DCM and MeOH (5 alternating rinses with 5 mL each) and dried 
under vacuum for 45 minutes. Product was weighed and transferred to flame dried vial 
for future use.
Polyyne Capping
Soluble alkyne (15 equiv.) was added to a flame dried vial containing the desired alcohol 
derivatized trityl resin and tetrahydrofuran (2 mL). The copper catalyst (20 mg, 1.06 
mmol) and tetramethylethylenediamine (20 pL, 0.132 mmol) were added to a separate 
flame-dried vial then dissolved in tetrahydrofuran (2 mL). The catalyst mixture was then 
added to the resin in one portion and stirred at 60 °C for 16 h. The resin was transferred 
to a syringe filter and washed with DCM and MeOH (5 alternating rinses with 5 mL each). 
The product was then cleaved from the resin by treatment with 2% TFA (DCM, 1 h) and 
filtered into a vial. If necessary, a short silica plug was utilized to remove unreacted 
starting material (1:1 EtOAc/Hex).
Analytical Data: Diyne NMR Listings
Compound 12: The solvent was removed in vacuo to give compound 12 as a white solid 
(5 mg, 0.032 mmol, 99%). *H NMR (400 MHz; CDCI3): 6 4.36 (s, 4H); GCMS (Rt=7.88 min) 
calculated for CH6 O2 110.0, found 110.1.
Compound 13: The solvent was removed in vacuo to give compound 13 as a solid (3mg, 
0.020 mmol, 56%). XH NMR (400 MHz; CDCI3): 6 7.49 (d, J = 8.0 Hz, 2H), 7.44 (d, J = 8.0 Hz, 
2H), 4.72 (s, 2H), 4.35 (s, 2H); GCMS (Rt=9.94 min) calculated for C1 2 H1 0 O2 186.1, found
186.1.
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Compound 14: The solvent was removed in vacuo to give compound 14 as a solid (3 mg, 
0.014 mmol, 40%). Using 7 as a starting material (3.5 mg, 0.032mmol, 91%). 1H NMR (400 
MHz; CD3OD): 6 5.21 (s, 2H), 4.35 (s, 2H), 3.39 (s,2H); GCMS (Rt=6.01 min) calculated for 
C6H7NO 109.1, found 109.1.
Compound 15: The solvent was removed in vacuo to give compound 15 as a solid (4 mg, 
0.029 mmol, 84%) XH NMR (400 MHz; CDCI3): 6 4.32 (s, 2H), 2.29 (t, J = 6.8 Hz,3H), 1.52 
(m, 2H), 1.42 (sextet, J = 7.2 Hz, 2H), 0.91 (t, J = 7.23 Hz,3H); GCMS (Rt=7.29 min) 
calculated for C9H12O 136.1, found 136.0.
Compound 16: The solvent was removed in vacuo to give compound 16 as a solid (4 mg, 
0.034 mmol, 95%). XH NMR (400 MHz; CDCI3): 6 7.49 (t, J = 5.9, 2H), 7.34-7.26 (m, 3H), 
4.45 (s, 2H), 1.94 (s, 1H); GCMS (Rt=9.20 min) calculated for CnHsO 156.1, found 156.2.
Compound 17: The solvent was removed in vacuo to give compound 17 as a solid (2 mg, 
0.015 mmol, 45%). JH NMR (400 MHz; CDCI3): 6 7.58 (d, J = 4.7 Hz, 1H), 7.28 (s,lH), 7.15 
(d, J = 4.7 Hz, 1H), 4.42 (s, 2H); GCMS (Rt=9.67 min) calculated for C9H6OS 162.0, found 
162.1.
Compound 18: The solvent was removed in vacuo to give compound 18 as a solid (6 mg, 
0.035 mmol, 99%) *H NMR (400 MHz; CDCI3): 6 7.44 (d, J = 7.6 Hz, 2H), 6.85 (d, J = 7.6, 
2H), 4.14 (s, 2H), 3.82 (s, 3H); GCMS (Rt=9.93 min) calculated for C1 2 H1 0O2 186.1, found 
186.2.
Compound 19: The solvent was removed in vacuo to give compound 19 as a solid (4 mg, 
0.026 mmol, 80%). *H NMR (400 MHz; CDCI3): 6 4.33 (s, 2H), 0.20 (s, 9H); GCMS (Rt=9.79 
min) calculated for CsH^OSi 152.1, found 152.1.
Compound 20: The solvent was removed in vacuo to give compound 20 as a solid (2 mg, 
0.019 mmol, 55%). XH NMR (400 MHz; CDCI3 ): 6 8.01 (d, J = 7.5 Hz, 1H), 7.65 (t, J = 7.4 Hz, 
1H), 7.32 (t, J = 7.5 Hz, 1H), 6.91 (d, J = 7.4 Hz, 1H), 4.38 (s, 2H). GCMS (Rt=8.77 min) 
calculated for C10H7NO 157.1, found 157.2
Compound 22: The solvent was removed in vacuo to give compound 22 as a solid. (4 mg, 
0.022 mmol, 76%). XH NMR (400 MHz; CDCI3): 6 7.40 (d, J=7.5 Hz, 2H), 7.33 (d, J=7.5 Hz, 
2H), 4.61 (s, 2H), 3.28 (s, 2H). GCMS (Rt=9.92 min) calculated for C1 2 H1 1 NO 185.1, found
185.2.
Compound 23: The solvent was removed in vacuo to give compound 23 as a solid (3 mg, 
0.024 mmol, 87%). *H NMR (400 MHz; CD3OD): 6 5.12 (s, 4H), 3.39 (s, 4H); GCMS (Rt=5.72 
min) calculated for C6 HgN2 108.1, found 108.1.
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Compound 24: The solvent was removed in vacuo to give compound 24 as a solid (3 mg, 
0.019 mmol, 71%). XH NMR (400 MHz; CD3 OD): 65.24 (s, 2H), 3.41 (s, 2H), 2.29 (t, J = 6 . 8  
Hz, 3H), 1.52 (m, 2H), 1.42 (m, 2H), 0.91 (t, J = 6 . 8  Hz, 3H); GCMS (Rt=7.19 min) calculated 
for C9H13N 135.1, found 135.2.
Compound 25 The solvent was removed in vacuo to give compound 25 as a solid (4 mg, 
0.026 mmol, 92%). *H NMR (400 MHz; CD3OD): 6  7.49 (t, J = 5.9, 2H), 7.34-7.26 (m,3H), 
5.21 (s, 2H), 3.35 (s, 2H); GCMS (Rt=8.14 min) calculated for C11H9N 155.1, found 155.2.
Compound 26: The solvent was removed in vacuo to give compound 26 as a solid (2 mg, 
0.013 mmol, 48%). XH NMR (400 MHz; CDCI3): 6  7.58 (d, J = 4.7 Hz, 1H), 7.28 (s,lH), 7.15 
(d, J = 4.7 Hz, 1H), 5.21 (s, 2H), 3.35 (s, 2H); GCMS (Rt=9.59 min) calculated for C9H7NS 
161.0, found 161.2.
Compound 27: The solvent was removed in vacuo to give compound 27 as a solid (4 mg, 
0.022 mmol, 79%). XH NMR (400 MHz; CD3OD): 6  7.34 (d, J = 7.6, 2H), 6.75 (d, J= 7.6, 2H), 
5.14 (s, 2H), 3.82 (s, 3H), 3.39 (s, 2H); GCMS (Rt=9.82min) calculated for C1 2 H1 1 NO 185.1, 
found 185.1.
Compound 28: The solvent was removed in vacuo to give compound 28 as a solid. (4 mg, 
0.023 mmol, 84%). XH NMR (400 MHz; CDCI3): 6  0.15 (s, 9H), 3.31 (s, 2H); GCMS (Rt=9.87 
min) calculated for C8 Hi3 NSi 151.1, found 151.1
Compound 29: The solvent was removed in vacuo to give compound 29 as a solid. (2 mg, 
0.011 mmol, 41%). *H NMR (400 MHz; CDCI3): 6  7.90 (t, J=7.5 Hz, 1H), 7.65 (d, J=7.4 Hz, 
1H), 7.6(d, J=7.4 Hz, 1H), 7.5 (t, J=7.4 Hz, 1H), 3.2 (s, 2H); GCMS (Rt=8.04 min) calculated 
for CioH8 N2 156.1, found 157.2.
Compound 31: The solvent was removed in vacuo to give compound 31 as a solid. (11 mg, 
0.044 mmol, 99%). XH NMR (400 MHz; CDCb): 6  7.55 (d, J=7.3 Hz, 4H), 7.35 (d, J=7.3 Hz, 
4H), 4.75 (s, 4H). GCMS (Rt=14.78 min) calculated for Ci8 Hi4 0 2 262.1, found 262.0.
Compound 32: The solvent was removed in vacuo to give compound 32 as a solid. (9 mg, 
0.043 mmol, 98%). :H NMR (400 MHz; CDCI3): 6  7.52 (d, J=7.5 Hz, 2H), 7.31 (d, J=7.4 Hz, 
2H), 4.73 (s, 2H), 2.32 (t, J=7.1 Hz, 2H), 1.56 (quintet, J=7.1 Hz, 2H), 1.42 (m, 2H), 0.95 (t, 
J=7.1 Hz, 3H); GCMS (Rt=9.85 min) calculated for C1 5 H1 6O 212.1, found 212.2.
Compound 33: The solvent was removed in vacuo to give compound 33 as a solid. (9 mg, 
0.042 mmol, 32%). 1H NMR (400 MHz; CDCI3): 6  7.53 (d, J=7.5 Hz, 4H), 7.45 (t, J=7.5 Hz, 
4H), 7.30 (m, J=7.5, 5H), 4.74 (s, 2H); GCMS (Rt=10.75 min) calculated for Ci7 Hi2 0 2 232.1, 
found 232.1.
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Compound 34: The solvent was removed in vacuo to give compound 34 as a solid. (4 mg, 
0.018 mmol, 42%). XH NMR (400 M H z; CDCIs): 6 7.51 (d, J=7.5 Hz, 2H), 7.31 (d,J=7.4 Hz, 
2H), 7.26 (s, 1H), 7.19 (d, J=2.8 Hz, 1H), 7.10 (d, J=2.8 Hz, 1H), 4.74 (s, 2H); GCMS (Rt=9.57 
min) calculated for C15H10OS 238.1, found 237.9.
Compound 35: The solvent was removed in vacuo to give compound 35 as a solid. (8 mg, 
0.032 mmol, 73%). XH NMR (400 MHz; CDCI3 ): 6 7.53 (d, J=7.5 Hz, 2H), 7.30 (d,J=7.5 Hz, 
2H), 7.40 (d, J=7.5 Hz, 2H), 6.95 (d, J=7.5 Hz, 2H), 4.65 (s, 2H), 3.96 (s, 3H); GCMS (Rt=13.10 
min) calculated for C1 8 H1 4O2 262.1, found 262.1.
Compound 36: The solvent was removed in vacuo to give compound 36 as a solid. (9 mg, 
0.038 mmol, 87%). *H NMR (400 MHz; CDCI3 ): 6  7.52 (d, J=7.3 Hz, 2H), 7.32 (d, J=7.3 Hz, 
2H), 4.76 (s, 2H), 0.27 (s, 9H); GCMS (Rt=9.41 min) calculated for Ci4 Hi6OSi 228.1, found
228.2.
Compound 37: The solvent was removed in vacuo to give compound 37 as a solid. (5 mg, 
0.023 mmol, 53%). XH NMR (400 MHz; CDCI3): 6  7.61 (t, J=8 . 6  Hz, 1H), 7.55 (t,J=8 . 6  Hz, 
1H), 7.53 (d, J=7.3 Hz, 2H), 7.40 (d, J=7.4 Hz, 1H), 7.31 (d, J=7.3 Hz, 2H), 7.25 (s, 1H), 4.65 
(s, 2H); GCMS (Rt=10.75 min) calculated for C6 H1 1NO 233.1, found 233.3.
Analytical Data: Polyyne NMR Listings
Compound 38: The solvent was removed in vacuo to give 38 as a solid (10 mg, 0.049 mmol, 
6 8 %) 1H NMR (400 MHz; CDCI3 ): 6  7.44 (d, J = 7.6 Hz, 2H), 6 . 8 6  (d, J = 7.6 Hz, 2H), 4.38 (s, 
2H), 3.82 (s, 3H); GCMS (Rt =11.02 min) calculated for C1 4 H1 0O2 210.2, found 210.3.
Compound 39: The solvent was removed in vacuo to give 39 as a solid (11 mg, 0.037 mmol, 
67%) XH NMR (400 MHz; CDCI3): 6  7.46 (d, J = 7.6 Hz, 2H), 6.84 (d, J = 7.6 Hz, 2H), 4.38 (s, 
2H), 3.82 (s, 3H); GCMS (Rt = 18.39 min) calculated for C1 6 H1 0O2 234.3, found 234.2.
Compound 40: The solvent was removed in vacuo to give 40 as a solid ( 8  mg, 0.031 mmol, 
44%) *H NMR (400 MHz; CDCI3): 6 7.42 (d, J = 7.6 Hz, 2H), 6.85 (d, J = 7.6 Hz, 2H), 4.42 (s, 
2H), 3.82 (s, 3H); GCMS (Rt =14.35 min) calculated for C1 8 H1 0O2 258.3, found 258.2.
Compound 41: The solvent was removed in vacuo to give 41 as a solid isolated as the TFA 
salt ( 8  mg, 0.032 mmol, 46%). XH NMR (400 MHz; CD3OD): 6  3.97 (s, 2H), 3.75 (s, 2H), 2.70 
(s, 2H); GCMS (Rt =7.03 min) calculated for C8 H7 NO 133.2, found 133.2.
Compound 42: The solvent was removed in vacuo to give 42 as a solid isolated as the TFA 
salt (9 mg, 0.032 mmol, 46%). XH NMR (400 MHz; CD3 OD): 6  4.00 (s, 2H), 3.58 (s, 2H), 2.95 
(s, 2H); GCMS (Rt =8.43 min) calculated for C10H7NO 157.2, found 157.2.
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Compound 43: The solvent was removed in vacuo to give 43 as a solid isolated as the TFA
salt (10 mg, 0.034 mmol, 48%). XH NMR (400 MHz; CD3OD): 6 4.00 (s, 2H), 3.55 (s, 2H),
2.98 (s, 2H); GCMS (Rt =9.15 min) calculated for C12H7 NO 181.2, found 181.9.
Compound 44: The solvent was removed in vacuo to give 44 as a solid (8 mg, 0.044 mmol, 
63%). *H NMR (400 MHz; CDCI3 ): 6 7.50 (t, J = 5.9, 2H), 7.38-7.28 (m, 3H), 4.45 (s, 2H), 1.94 
(s, 1H); GCMS (Rt =15.06 min) calculated for CbHsO: 180.2, found 180.2.
Compound 45: The solvent was removed in vacuo to give 45 as a solid (9 mg, 0.044 mmol, 
63%). XH NMR (400 MHz; CDCI3 ): 6 7.55 (t, J = 5.9, 2H), 7.40-7.30 (m, 3H), 4.45 (s, 2H), 1.94 
(s, 1H); GCMS (Rt =10.08 min) calculated for CisHsO: 204.2, found 204.2.
Compound 46: The solvent was removed in vacuo to give 46 as a solid (9 mg, 0.039 mmol, 
56%). *H NMR (400 MHz; CDCI3 ): 6 7.56 (t, J = 5.9, 2H), 7.44-7.38 (m, 3H), 4.45 (s, 2H), 1.94 
(s, 1H); GCMS (Rt = 9.90 min) calculated for C1 7 H8 O: 228.3, found 228.3.
Compound 47: The solvent was removed in vacuo to give 47 as a solid (6 mg, 0.037 mmol, 
53%) XH NMR (400 MHz; CDCI3 ): 6 4.32 (s, 2H), 2.30 (t, J = 6.8 Hz, 3H), 1.55 (m, 2H), 1.42 
(sextet, J = 7.2 Hz, 2H), 0.93 (t, J = 7.23 Hz, 3H); GCMS (Rt = 10.61 min) calculated for 
C1 1 H1 2 O 160.2, found 160.2.
Compound 48: The solvent was removed in vacuo to give 48 as a solid (5 mg, 0.027 mmol, 
38%) XH NMR (400 MHz; CDCI3): 6 4.36 (s, 2H), 2.30 (t, J = 6.8 Hz, 3H), 1.55 (m, 2H), 1.42 
(sextet, J = 7.2 Hz, 2H), 1.00 (t, J = 7.23 Hz, 3H); GCMS (Rt = 10.28 min) calculated for 
C13H120 184.2, found 184.2.
Compound 49: The solvent was removed in vacuo to give 49 as a solid (9 mg, 0.028 mmol, 
41%) XH NMR (400 MHz; CDCI3): 6 4.38 (s, 2H), 2.35 (t, J = 6.8 Hz, 3H), 1.60 (m, 2H), 1.42 
(sextet, J = 7.2 Hz, 2H), 1.02 (t, J = 7.23 Hz, 3H); GCMS (Rt = 11.71 min) calculated for 
C15H12O 208.3, found 208.3.
Compound 50: The solvent was removed in vacuo to give compound 50 as a white solid 
(4 mg, 0.026 mmol, 82%). *H NMR (400 MHz; CDCI3): 6 4.36 (s, 4H); GCMS calculated for 
C8H60 2 134.0, found 134.1.
Compound 51: The solvent was removed in vacuo to give compound 51 as a white solid 
(3 mg, 0.018 mmol, 57%). 1H NMR (400 MHz; CDCI3): 6 4.38 (s, 4H); GCMS calculated for 
C1 0 H6 O2 158.0, found 158.0.
Compound 52: The solvent was removed in vacuo to give compound 52 as a white solid 
(3 mg, 0.016 mmol, 49%). 2H NMR (400 MHz; CDCI3): 6 4.35 (s, 4H); GCMS calculated for 
Ci2H60 2 182.0, found 182.1.
Compound 53: The solvent was removed in vacuo to give compound 53 as a solid (2 mg,
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0.011 mmol, 34%). *H NMR (400 MHz; CDCI3): 6 8.01 (d, J = 7.5 Hz, 1H), 7.65 (t, J = 7.4 Hz, 
1H), 7.32 (t, J = 7.5 Hz, 1H), 6.91 (d, J = 7.4 Hz, 1H), 4.38 (s, 2H). GCMS calculated for 
C12H7NO 181.1, found 181.2.
Compound 54: The solvent was removed in vacuo to give compound 54 as a solid (2 mg, 
0.009 mmol, 30%). XH NMR (400 MHz; CDCI3): 6 8.01 (d, J = 7.5 Hz, 1H), 7.65 (t, J = 7.4 Hz, 
1H), 7.32 (t, J = 7.5 Hz, 1H), 6.91 (d, J = 7.4 Hz, 1H), 4.38 (s, 2H). GCMS calculated for 
C14H7NO 205.1, found 205.1.
Compound 55: The solvent was removed in vacuo to give compound 55 as a solid (2 mg,
0.008 mmol, 27%). XH NMR (400 MHz; CDCI3 ): 6 8.01 (d, J = 7.5 Hz, 1H), 7.65 (t, J = 7.4 Hz, 
1H), 7.32 (t, J = 7.5 Hz, 1H), 6.91 (d, J = 7.4 Hz, 1H), 4.38 (s, 2H). GCMS calculated for 
Ci6H7NO 229.1, found 229.2.
Compound 56: The solvent was removed in vacuo to give 56 as a solid. (6 mg, 0.024 mmol, 
56%). XH NMR (400 MHz; CDCI3): 6 7.55 (d, J=7.4 Hz, 2H), 7.50 (d, J=7.4 Hz, 2H), 7.38 (d, J= 
7.4 Hz, 2H), 6.89 (d, J= 7.4 Hz, 2H), 4.75 (s, 2H), 3.83 (s, 3H); GCMS (Rt =16.89 min) 
calculated for C20H14O2 286.3, found 286.2.
Compound 57: The solvent was removed in vacuo to give 57 as a solid. (7 mg, 0.022 mmol, 
52%). 2H NMR (400 MHz; CDCI3 ): 6 7.98 (d, J=7.4 Hz, 2H), 7.58 (d, J=7.4 Hz, 2H), 7.50 (d, 
J=7.4 Hz, 2H), 6.95 (d, J=7.4 Hz, 2H), 4.75 (s, 2H), 3.85 (s, 3H); GCMS (Rt =13.38 min) 
calculated for C2 2 H1 4 O2 310.4, found 310.3.
Compound 58: The solvent was removed in vacuo to give 58 as a solid. (8 mg, 0.023 mmol, 
55%). *H NMR (400 MHz; CDCI3): 6 7.80 (d, J=7.5 Hz, 2H), 7.50 (d, J=7.5 Hz, 2H), 7.45 (d, 
J=7.5 Hz, 2H), 6.85 (d, J=7.5 Hz, 2H), 3.80 (s, 2H), 2.85 (s, 3H); GCMS (Rt =11.43 min) 
calculated for C24H14O2 334.4, found 334.3.
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Chapter 6-Solid-Supported Glaser-Hay Couplings in the Microwave
I. Introduction
Microwaves are a component of the electromagnetic spectrum with wavelengths 
between 1 mm to 1 m, which corresponds to frequencies that vary from 0.3 and 300 GHz. 
This form of radiation is located between infrared radiation and radio waves on the 
electromagnetic spectrum . 9 (Figure 6.1)
The Electromagnetic Spectrum
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Figure 6.1: Electromagnetic Spectrum . 7
In the past 30 years, microwaves have found widespread use in organic chemistry. 
Traditionally, heated organic reactions are performed on a hot plate, in a heating jacket, 
or in an oil bath. Unfortunately, these methods rely on convection and do not allow heat 
energy to transfer evenly throughout the reaction. These methods can also be slow to 
heat and can require consistent maintenance to regulate. To alleviate these temperature 
issues, microwave radiation has proven to be advantageous. Microwave technology has
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also shown advantages such as the ability to significantly decrease reaction times and 
increase product yields.
Microwave radiation couples rotational energy to molecules in a reaction in order 
to produce efficient and thorough internal reaction heating. The two main components 
of microwave radiation involve an electric field and a magnetic field and can be referred 
to as dielectric heating.13 In order for a reaction to increase in temperature when 
introduced to microwave radiation, the molecules present must have a dipole moment. 
The dipole will align with the electric field component and rotate to generate heat on a 
molecular level.9 (Figure 6.2)
Figure 6.2: When introduced to an oscillating electric field, the dipoles of the molecules 
in the reaction will align and expend energy in order to conduct heat for the reaction.9
In order for the dipole of the molecules involved in the reaction to directly interact 
with the oscillating electric field, the solvent used for a microwave reaction should lack a 
permanent dipole moment of its own, rendering it transparent to the microwave 
irradiation. Good solvents (that have low dielectric constants) for use with microwave 
synthesis include ethyl acetate, benzene, and tetrahydrofuran. Similarly, by using
I
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microwave transparent vessels such as a borosilicate glass vessel these mechanisms can 
combine to provide a consistent heating of the reaction. 14 The advantage of using 
microwave radiation to evenly heat a reaction is illustrated in Figure 6.3.
Figure 6.3: When a reaction vessel is heated through microwave radiation in the proper 
instrument (left), the heat is distributed evenly throughout the solution. However, when 
heated by a conventional oil bath (right), the reaction vessel is heated first, causing heat 
to be distributed improperly and the solution to remain at a lower temperature . 4
Initially, scientific microwaves were found to be of great importance to the 
medicinal and combinatorial chemistry industries. They then were transitioned into great 
use in the fields of synthesis and organic chemistry, and most recent, have been found 
helpful in the developing area of green chemistry. 3 They were first introduced into organic 
chemistry in 1986 through a study of multiple reactions involving different solvents. 1 It 
was discovered that reaction rates could be rapidly decreased through the use of the 
microwaves. The first researchers focused on using microwave irradiation to study and 
decrease reaction times of Diels-Alder, Claisen, and -ene reactions. 2 After this initial
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report, microwaves began to find widespread use throughout organic chemistry,
affording increased product yields and shorter reaction times.
The first scientific research performed with microwave technology used 
commercial microwave ovens that can be typically find in a kitchen. However, these were 
found to be unsafe, and would sometimes cause explosions. 9 Domestic microwaves also 
did not possess the ability to consistently control time and temperature, and did not 
provide a specific chamber for the reaction that allowed for the application of pressure 
to the reaction. Moreover, the microwaves themselves were unable to be focused on the 
reaction, and thus did not confer an efficient mechanism for heating. Therefore, a 
scientific microwave was introduced into the industry that would allow for a vessel to be 
subjected to a focused beam of microwave irradiation, and a reaction to occur with 
consistent power, temperature, and pressure settings. 15 (Figure 6.4)
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Figure 6.4: Diagram demonstrating a CEM Microwave and its ability to hold a transparent 
reaction vessel and allow an even, pressurized distribution of microwave radiation . 17
Due to the increased availability of scientific microwaves, as well as an improved 
knowledge of their uses and function, microwaves are becoming a common tool in 
modern organic chemistry. To date, numerous reactions have been shown to occur at an 
accelerated reaction rate in a microwave. Leadbetter et al. report performing a 
microwave-mediated Suzuki coupling of boronic acids and aryl halides in only 5-10 
minutes . 10 Heck reactions, typically involving alkenes and organohalides, were reported 
to occur in the microwave in under 5 minutes, compared to a normal multiple hour 
reaction tim e . 16 Of recent importance is the application of microwave chemistry to the 
popular Click reactions that are finding widespread use throughout the areas of 
biochemistry, medicinal chemistry, and organic chemistry. 11 Microwave-mediated
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synthesis has also been expanded to Diels-Alder reactions, cycloadditions, oxidations, 
Mitsunobu reactions, and glycosylations. 8
With a significant amount of successful microwave-mediated reactions presented 
in literature, we aimed to transition the previously reported solid-supported Glaser-Hay 
reactions into the microwave. In doing so, the potential to significantly reduce the 
reaction time of the Glaser-Hay reactions from 16 hours to minutes represented a 
substantial enhancement to the methodology.
II. Results and Discussion
A. Development o f Glaser-Hoy Reaction Conditions Utilizing the Microwave
With previously optimized solid-supported Glaser-Hay reaction conditions (see 
Chapter 5), efforts were made to transition the reactions into the microwave and create 
a small library of asymmetrical diynes. By utilizing microwave-mediated synthesis, the 
goal was to drastically reduce reaction times, while still synthesizing the asymmetric diyne 
in good yield. Initial microwave attempts were performed with a resin immobilized with 
propargyl alcohol and phenylacetylene was employed as the soluble alkyne. 
Phenylacetylene was initially selected for optimization due to its high microwave 
reactivity and ability to easily track the reaction via TLC analysis. THF remained a viable 
solvent choice due to its microwave transparency.
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To begin, the reactions were performed using the described conditions optimized 
previously. (Scheme 6.1)
Scheme 6.1
It was believed that by irradiating the reactions with specific microwave powers 
the reactions would be driven to completion in a matter of minutes. However, 10-minute 
reaction attempts at constant power settings of 100 W, 200 W, or 300 W, showed little 
to no product formation. It was discovered that while irradiating with the constant power, 
the temperature of the microwave vessel would rise between 140°C and 180°C. This high 
temperature was hypothesized to be potentially degrading the resin, forming little 
product. Moving forward, conditions were altered using a constant temperature setting 
in order to control the heat and ideally prevent resin degradation.
Gratifyingly, initial attempts with the controlled temperature setting began to 
yield diyne product. Numerous reaction times at varied temperatures were examined 
with the phenylacetylene and propargyl alcohol immobilized resin in order to find the 
optimal conditions producing the highest yield. (Table 6.1)
1) 0.6 equiv. Cul 
0.5 equiv. TMEDA 
THF r
R
2) 2% TFA
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Table 6.1: Tested and varied microwave conditions.
Cul/TMEDA ^
■ °s__________.  ™ ----------- ----- O-K
Varied Microwave 
Settings
—o
Temperature Time %Yield
40 °C 2 0 : 0 0  min. No Product
60 °C 05:00 min. 26%
60 °C 1 0 : 0 0  min. 77%
80 °C 05:00 min. No Product
80 °C 1 0 : 0 0  min. 77%
100 °C 05:00 min. No Product
100 °C 1 0 : 0 0  min. 63%
As both the 60 °C for 10:00 minutes and the 80 °C for 10:00 minutes reactions 
produced the same yield, the optimum and best conditions for the reaction were believed 
to be at 60 °C for 10:00 minutes. This demonstrated that the overall reaction time could 
be drastically reduced from the previously established time of 16 hours to a mere 1 0  
minutes, which would allow for rapid preparation of asymmetrical diynes. Moving 
forward, it was believed that these conditions could be applied to a number of terminal 
alkynes in order to prepare a small library of solid-supported Glaser-Hay microwave 
reactions.
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B. Preparation o f a Microwave Synthesized Diyne Library
Continued efforts were made to analyze the methodology via the synthesis of 
additional asymmetrical diynes using microwave irradiation. As elucidated with the 
propargyl alcohol resin and phenylacetylene coupling, it was believed that reactions could 
occur at 60 °C for 10:00 minutes. The propargyl alcohol resin was utilized with the 
following terminal alkynes: propagyl alcohol, ethynylanisole, hexyne, propargyl amine, 
and ethynylpyridine. Upon completion of microwave irradiation, reactions were 
transferred to a filtered syringe and washed 5 x with DCM and MeOH to remove catalyst 
and unreacted alkyne. The product was then cleaved from the resin with 2% 
trifluoroacetic acid in DCM, the product was filtered into a dry vial, and the solvent was 
removed in vacuo. To analyze the reaction, each product was examined by ^  NMR. Upon 
initial reaction attempts at 60°C for 10:00 minutes with each soluble alkyne, it was found 
that some reactions did not afford any product. Moving forward, reaction conditions were 
altered to yield product with the varied alkynes to elucidate a general microwave 
protocol. Temperatures between 60°C and 120°C and reaction times from 10:00 minutes 
to 20:00 minutes were examined. The reactions were then analyzed via 1H NMR and yields 
were determined. Optimum reaction conditions and the produced yields when reacted 
with the propargyl alcohol loaded resin can be found in Table 6.2.
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Table 6.2
1) Cul/TMEDA 
THF
Thermal or Microwave |_jq 
x ----- r? \+ -----  K  —
2) 2% TFA, 1 hr, rt.
—  —  R
Alkyne Product % Yield Thermal
% Yield 
Microwave
Ph. H0
5 9 ^:>» Ph
95% 77% *
60
84% 67%
61 T I 99% 75%
6 2  I |
55% 90%
h2 n " ^
6 3 ^  NH2
40% 92%
64
99% 90%
*Can be performed at 60°C for 10:00.
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Using the propargyl alcohol immobilized resin, product formation was seen with 
temperature settings of 80° for 20 minutes. Products were obtained in good purity and 
needed no further purification. Based on yields, the alkyne reactants including a nitrogen 
atom reacted better under microwave conditions than under standard thermal 
conditions. This may be due to the fact that nitrogen containing compounds are very 
microwave reactive, as they exhibit a strong dipole moment, increasing their interactions 
with the microwave irradiation. Moreover, we hypothesize that due to the quick rate of 
reaction in the microwave, no catalyst poisoning occurs from soluble alkyne coordination 
with the copper as seen in the original methodology (See Chapter 5). Ultimately, this 
indicates that the microwave will be a useful tool for Glaser-Hay reactions involving basic 
functionalities. The compound containing the hexyne moiety exhibits the lowest yield of 
the six soluble alkynes, perhaps due to the fact that an alkyl side chain is not very 
microwave reactive. Overall, we determined that the utilization of microwave technology 
with the solid-supported Glaser-Hay methodology permitted synthesis of a small library 
of asymmetric diynes in minutes as opposed to the standard 16 hour reaction time.
C. Investigations with Alternative Immobilized Alkynes
In order to expand the scope of this methodology, a trityl chloride resin was 
loaded with 4-ethylnyl benzyl alcohol. This immobilized resin was then exposed to the 
same alkynes and similar microwave conditions to generate a small library of diynes 
created with the 4-ethynyl benzyl alcohol resin. Results can be seen in Table 6.3
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Table 6.3
O “ 0
+  = — R
1) Cul/TMEDA 
THF
Thermal or Microwave
-------------------------
2) 2% TFA, 1 hr, rt.
HO
Alkyne Product % Yield Thermal
Ph
h2n ^ ^
96%
98%
73%
53%
96%
40%
*Can be performed at 80°C for 20:00.
% Yield 
Microwave
78%*
76%
76%
86%
86%
86%
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Initial reaction attempts afforded a mix of starting material and desired 
asymmetrical product. This can be attributed to the fact that the 4-EBA functionality is 
highly adsorbing of microwave irradiation, heating much more rapidly than the 
immobilized propargyl alcohol resin. Overall, this resulted in very low microwave input 
into the reactions. Because of this, the 4EBA resin required higher temperatures, as well 
as microwave pulses to drive the reaction to completion.
To alleviate the mixture of starting material and product, 2:00 minute reaction 
pulses at 1 2 0 ° were used to total a 2 0 : 0 0  minute reaction time, allowing the reaction to 
return to room temperature between the pulses. By pulsing the reaction, the microwave 
power was kept higher and came in bursts rather than one initial ramp of power that 
decreases overtime. These pulses were shown to drive most reactions to completion and 
higher yields were obtained. However, reaction with hexyne was still not driven to 
completion and a mix of cleaved 4-ethynylbenzyl alcohol and desired product was could 
be seen on XH NMR. Therefore, a column was used to obtain the desired asymmetrical 
4EBA-hexyne product in low yield. This follows the pattern shown previously where the 
hexyne yield on the propargyl alcohol immobilized resin was also one of the lowest. The 
alkyl side-chain is microwave transparent and therefore produces a low yield of desired 
product. However, other alkynes possessing more reactive species were shown to react 
better with irradiation and produce asymmetrical products in good yields using the 
microwave vessel. This was especially the case in regards to the pyridine and amino
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functional groups, which both produced good yields due to their good microwave 
irradiation absorption properties and increased microwave reactivity.
Overall, it can has been demonstrated that solid-supported Glaser-Hay reactions 
can take place in the microwave using mild reaction conditions. Further research could 
be performed in order to produce even higher yields and eliminate unwanted side 
products from various immobilized resins. Moreover, more complex soluble and 
immobilized alkynes can be explored to further probe the limits of the microwave 
mediated reaction.
III. Materials and Methods
General. Solvents and reagents were obtained from either Sigma-Aldrich or Fisher 
Scientific and used without further purification, unless noted. Tritylchloride resin, 100- 
200 mesh, 1% DVB crosslinking, was purchased from Advanced Chemtech. Microwave 
reactions took place in a CEM Discover System, model no. 908005. Reactions were 
conducted under ambient atmosphere with non-distilled solvents. NMR data were 
acquired on a Varian Gemini 400 MHz.
Immobilization of Alcohol onto Trityl Chloride Resin in Low Loading Conditions
Trityl chloride resin (200 mg, 0.36 mmol, 1 equiv.) and dichloromethane (5 mL) were 
added to a flame dried vialS. The resin was swelled at room temperature with gentle 
stirring for 15 min. Desired alcohol (~1.2 equiv.) was added to reaction, followed by 
triethylamine (10.0 pL, 0.072 mmol, 0.2 equiv). The mixture was stirred at room 
temperature for 16 h. The resin was transferred to a syringe filter and washed with DCM
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and MeOH (5 alternating rinses with 5 mL each). The resin was swelled in CH2 CI2 and dried 
under vacuum for 45 min before further use.
Sample of Glaser Hay Coupling Protocol at 60 °C
Soluble alkyne (0.70 mmol, 10 equiv.) was added to a flame dried microwave vial 
containing the propargyl alcohol derivatized trityl resin (100 mg, 0.07 mmol, 1 equiv.), 
and tetrahydrofuran (2.0 mL). The copper catalyst (10 mg, 0.053 mmol.) and 
tetramethylethylenediamine (50 pL.) were added to a separate flame-dried vial then 
dissolved in tetrahydrofuran (2.0 mL). The catalyst mixture was then added to the resin 
in one portion and placed in the microwave reactor to run for allotted time at specific 
temperature. The completed reaction was transferred to a syringe filter and washed with 
DCM and MeOH (5 alternating rinses with 5 mL each). The product was then cleaved from 
the resin by treatment with 2% TFA (DCM, 1 h) and filtered into a vial. Product was 
analyzed via 1H NMR.
Analytical Data
Compound 59: The solvent was removed in vacuo to give compound 59 as a solid (6 mg, 
0.039 mmol, 77%). *H NMR (400 MHz; CDCI3 ): 6 7.49 (t, J = 5.9, 2H), 7.34-7.26 (m, 3H), 
4.45 (s, 2H), 1.94 (s, 1H); GCMS (Rt=9.20 min) calculated for CnHgO 156.1, found 156.2.
Compound 60: The solvent was removed in vacuo to give compound 60 as a solid (5 mg, 
0.034 mmol, 67%) XH NMR (400 MHz; CDCI3 ): 6  4.32 (s, 2H), 2.29 (t, J = 6 . 8  Hz, 3H), 1.52 
(m, 2H), 1.42 (sextet, J = 7.2 Hz, 2H), 0.91 (t, J = 7.23 Hz, 3H); GCMS (Rt=7.29 min) 
calculated for C9H12O 136.1, found 136.0.
Compound 61: The solvent was removed in vacuo to give compound 61 as a solid (7 mg, 
0.038 mmol, 75%) XH NMR (400 MHz; CDCI3): 6  7.44 (d, J = 7.6 Hz, 2H), 6.85 (d, J = 7.6, 
2H), 4.14 (s, 2H), 3.82 (s, 3H); GCMS (Rt=9.93 min) calculated for C1 2 H1 0 O2 186.1, found
186.2.
Compound 62: The solvent was removed in vacuo to give compound 62 as a solid (7 mg, 
0.045 mmol, 90%). *H NMR (400 MHz; CDCI3): 6  8.01 (d, J = 7.5 Hz, 1H), 7.65 (t, J = 7.4 Hz,
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1H), 7.32 (t, J = 7.5 Hz, 1H), 6.91 (d, J = 7.4 Hz, 1H), 4.38 (s, 2H). GCMS (Rt=8.77 min) 
calculated for C1 0 H7 NO 157.1, found 157.2.
Compound 63: The solvent was removed in vacuo to give compound 63 as a solid (5 mg, 
0.046 mmol, 92%). Using 7 as a starting material (3.5 mg, 0.032mmol, 91%). XH NMR (400 
MHz; CD3OD): 6 5.21 (s, 2H), 4.35 (s, 2H), 3.39 (s, 2H); GCMS (Rt=6.01 min) calculated for 
C6 H7NO 109.1, found 109.1.
Compound 64: The solvent was removed in vacuo to give compound 64 as a solid (5 mg, 
0.045 mmol, 90%). :H NMR (400 MHz; CDCI3): 6  4.36 (s, 4H); GCMS (Rt=7.88 min) 
calculated for C6 H6 O2 1 1 0 .0 , found 1 1 0 .1 .
Compound 65: The solvent was removed in vacuo to give compound 65 as a solid. (9 mg, 
0.039 mmol, 78%). *H NMR (400 MHz; CDCI3): 6  7.53 (d, J=7.5 Hz, 4H), 7.45 (t, J=7.5 Hz, 
4H), 7.30 (m, J=7.5, 5H), 4.74 (s, 2H); GCMS (Rt =10.75 min) calculated for C17H12O2 232.1, 
found 232.1.
Compound 6 6 : The solvent was removed in vacuo to give compound 6 6  as a solid. (4 mg, 
0.019 mmol, 38%). XH NMR (400 MHz; CDCI3): 6 7.52 (d, J=7.5 Hz, 2H), 7.31 (d, J=7.4 Hz, 
2H), 4.73 (s, 2H), 2.32 (t, J=7.1 Hz, 2H), 1.56 (quintet, J=7.1 Hz, 2H), 1.42 (m, 2H), 0.95 (t, 
J=7.1 Hz, 3H); GCMS (Rt =9.85 min) calculated for C1 5 H1 6 O 212.1, found 212.2.
Compound 67: The solvent was removed in vacuo to give compound 67 as a solid. (10 mg, 
0.038 mmol, 76%). XH NMR (400 MHz; CDCI3): 6  7.53 (d, J=7.5 Hz, 2H), 7.30 (d, J=7.5 Hz, 
2H), 7.40 (d, J=7.5 Hz, 2H), 6.95 (d, J=7.5 Hz, 2H), 4.65 (s, 2H), 3.96 (s, 3H); GCMS (Rt =13.10 
min) calculated for C1 8 H1 4O2 262.1, found 262.1.
Compound 6 8 : The solvent was removed in vacuo to give compound 6 8  as a solid. (10 mg, 
0.043 mmol, 8 6 %). XH NMR (400 MHz; CDCI3): 6 7.61 (t, J=8 . 6  Hz, 1H), 7.55 (t, J=8 . 6  Hz, 
1H), 7.53 (d, J=7.3 Hz, 2H), 7.40 (d, J=7.4 Hz, 1H), 7.31 (d, J=7.3 Hz, 2H), 7.25 (s, 1H), 4.65 
(s, 2H); GCMS (Rt =10.75 min) calculated for CeHnNO 233.1, found 233.3
Compound 69: The solvent was removed in vacuo to give compound 69 as a solid. ( 8  mg, 
0.043 mmol, 8 6 %). *H NMR (400 MHz; CDCI3): 6 7.40 (d, J=7.5 Hz, 2H), 7.33 (d, J=7.5 Hz, 
2H), 4.61 (s, 2H), 3.28 (s, 2H). GCMS (Rt=9.92 min) calculated for C1 2 H1 1 NO 185.1, found
185.2.
Compound 70: The solvent was removed in vacuo to give compound 70 as a solid ( 8  mg,
0.043 mmol, 8 6 %). XH NMR (400 MHz; CDCI3): d 7.49 (d, J = 8.0 Hz, 2H), 7.44 (d, J = 8.0 Hz, 
2H), 4.72 (s, 2H), 4.35 (s, 2H); GCMS (Rt=9.94 min) calculated for C1 2 H1 0O2 186.1, found 
186.1.
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Chapter 7- Glaser-Hay Bioconjugation
I. Introduction
A. An Introduction to Bioconjugation
The term bioconjugation denotes a reaction that links together two molecules, 
typically with at least one of the two being of biological origin or relevance. (Figure 7.1) 
Many bioconjugation methods involve the incorporation of biological probes, antibodies, 
or enzymes. The bioconjugation is also often characterized by the type of linkage it 
produces between the two molecules, be it a covalent or non-covalent interaction.
_  Conjugation reaction ^O * Q — ------► Q-O
Conjugate A Conjugate B 
Figure 7.1: Standard depiction of molecular conjugation.
Bioconjugation techniques have proven to be an effective strategy for studying
numerous biological process and have also paved the way for drug and therapeutic
discovery. Often they are utilized in many industries including medical, diagnostic, life
science, and materials science. 1 For example, a clinical chemistry study reported the
ability to conjugate intelligent polymers to protein bodies. Intelligent polymers are
polymeric molecules that respond to small changes in their environment such as
temperature, pH, or light with changes in their physical state or properties. Incorporation
of these as bioconjugates allows for the direct study of the effects of changes in the
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protein environment leading to further studies in diagnostics as a result of the polymer 
response to environmental stimuli. 3
Numerous bioconjugations involving protein and a conjugate are well known, 
including streptavidin-enzyme, antibody-enzyme, and antibody-drug conjugates. There 
are, however, limitations to bioconjugate formation. One major limitation is the site- 
specific attachment of the desired conjugate. For example, to an antibody containing 
numerous lysine sites, the researcher does not always have complete control over which 
site the conjugate will attach, leading to a potential loss of function of the antibody. 
Therefore, it would be beneficial to site-specifically control the attachment site for 
bioconjugates, in order to ensure the proper function of the developed system. 1 A well- 
known strategy of site-specific bionconjugation involves the use of unnatural amino acids 
in order to introduce a functional group to participate in a selective reaction. Recent 
advances in protein alteration and bioconjugation have begun to introduce functionalities 
that may undergo photocrosslinking, alkyne coupling reactions, oxime formations, and 
1,3 dipolar cycloadditions. 1 The 1,3 dipolar cycloadditions were first introduced by Rolf 
Huisgen in 1961 and have proven very popular among many researchers.4  These 
reactions take place between an azide and an alkyne functional group (either terminal or 
internal) to give rise to a stable, covalent triazole linker. 5 (Scheme 7.1)
Scheme 7.1
Cu
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Although this reaction has found a wide variety of uses in the area of "click" 
chemistry, it is still necessary to pursue other reactions that may be ideal candidates for 
bioconjugations. There are a variety of other reactive moieties present within already 
developed UAAs that could be efficiently utilized for bioconjugations, and the pursuit of a 
wider range of reaction possibilities is exciting in the area of bioconjugate chemistry.
As mentioned, unnatural amino acids have promising uses in the area of 
bioconjugation. Figure 7.2 shows a variety of known phenylalanine derivatives that 
involve unique functional groups that can undergo potential bioconjugation reactions. A 
halogenated phenylalanine (7.2.A) may be reacted in numerous ways. For example, a 
boronic ester can be introduced to afford a Suzuki coupling reaction . 9 A halogenated 
species can also be used for a Heck reaction when introduced to an alkene functional 
group7, or for Songoshira coupling when reacted with a terminal alkyne. 8 Phenylalanine 
derivatives containg azide (7.2.B) or terminal alkynes (7.2.C) can undergo the popular 
Huisgen reaction5, and acetyl groups (7.2.D) on phenylalanine can be used to form oxime 
linkages. 1 0
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Figure 7.2: Various phenylalanine derivatives that may be incorporated into proteins in 
order to undergo a variety of reactions. Introducing the reactive functional groups allows 
for many possible bioconjugation methods.
In order to ensure an effective bioconjugation reaction, the reaction technique 
should include mild aqueous reaction conditions. The reaction should also be able to 
produce a stable bond between reactants with a high degree of chemoselectivity and 
bioorthogonality. 11
B. Benefits o f Using Glaser-Hay Coupling fo r  Bioconjugation
Due to the recent optimization of the Glaser-Hay reaction for solid-supported 
synthesis, it was envisioned that this reaction could also be employed for bioconjugations. 
The Glaser-Hay reaction involves the coupling of two terminal alkynes to produce a linear 
moiety that could give rise to further reactions or biological bioconjugate additions. It is 
an optimal reaction for bioconjugation due to the formation of the very stable covalent 
carbon-carbon bond under mild reaction conditions. Additionally, it provides a linear,
91
highly oxidized product that could be further reacted using numerous known reactions or 
used for additional biological conjugate reactions. This reaction also tolerates a wide 
range of functional groups, and therefore a plethora of reaction partners containing 
alkyne functional groups could potentially be employed and possibly give rise to new 
therapeutic agents.
II. Results and Discussion
A. Utilizing the Glaser-Hay Reaction fo r  Protein Bioconjugation
Before employing the Glaser-Hay reaction toward bioconjugations, the reaction 
had to be translated to aqueous conditions. Upon a thorough literature search, we could 
not find evidence that the Glaser-Hay reaction had been previously performed in an 
aqueous solution. Therefore, a proof-of-concept Glaser-Hay reaction was conducted in 
water utilizing phenylacetylene to afford a homodimer. It was hoped that the previously 
developed solid-supported Glaser-Hay methodology (see chapter 5) would easily 
translate to aqueous conditions using the same protocol. To start, phenylacetylene was 
added to a vial along with the copper catalyst system consisting of Cul and TMEDA. In 
place of THF, water was used as a solvent for both the alkyne and the copper catalyst 
system. This reaction was then stirred at room temperature for 16 hours. Upon reaction 
completion, the product was extracted using EtOAc and H2 O, and solvent removed in 
vacuo. Gratifyingly, homodimer product was obtained in good yield (96%) without further 
purification, proving that the Glaser-Hay reaction could be performed in an aqueous,
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biological setting. Due to the success of the aqueous conditions, it was believed that the 
Glaser-Hay coupling would be effective in the aqueous conditions required for protein 
bioconjugations.
To apply the Glaser-Hay reaction to a protein bioconjugation, the protein must 
contain an alkyne functional group to act as a handle for reaction with a second alkyne 
functional group on the molecule designated for conjugation. In order to introduce the 
alkyne functional group, the approach using orthogonal tRNAs and aminoacyl-tRNA 
synthetases described in Chapter 1 was utilized to incorporate an alkynyl unnatural amino 
acid, propargyloxyphenylalanine (Figure 7.3), into a reporter protein. The synthesis of the 
UAA was performed based on literature conditions. 2 Conveniently, an aaRS has already 
been evolved to recognize the alkynyl UAA, and integrated into an expression plasmid 
known as pEVOL-pPrF. 2
O
Figure 7.3: Propargymoxyphenylalanine UAA employed in bioconjugations.
GFP is an ideal reporter protein due to its high fluorescence activity, and was 
therefore an optimal choice for bioconjugation optimization. The GFP gene used in this 
research contains a TAG codon introduced at the surface exposed residue at codon 151
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which allows for an accessible site for UAA expression. As well as being convenient for 
UAA expression, a surface exposed residue is important for bioconjugation. If the residue 
is buried within the protein, bioconjugation reactions would be much harder or 
impossible to perform . 6
When the mutated mRNA transcript with the inserted TAG codon is introduced to 
the ribosome, protein translation takes place, installing the UAA when it is present in the 
expression media. However, when an unnatural amino acid is not present, the TAG codon 
terminates translation and full protein is not produced. Overall, it was believed that by 
inserting the alkynyl handle at this position, bioconjugation attempts utilizing the Glaser- 
Hay reaction could be investigated. (Figure 7.4)
Figure 7.4: The structure of GPF consists of an outer beta-barrel and an internal 
chromophore . 13 This diagram shows GFP with alkynyl UAA insertion at the surface- 
exposed position 151 undergoing the envisioned Glaser-Hay reaction to produce the 
conjugated protein species.
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BL-21(DE3) E. coli were co-transformed with the pEVOL-pPrF and pET-sfGFP- 
Y151TAG plasmids and the mutant GFP was expressed in both the presence and absence 
of the alkynyl UAA. Due to the TAG codon at position 151, when pPrF is not introduced to 
the protein, translation terminates which is indicated by absence of the GFP band in the 
SDS-PAGE gel. (Figure 7.7; Lanes 6  and 7) Lane 6  shows presence of the GFP-pPrF-151 
mutant which permitted research of Glaser-Hay bioconjugation optimization to proceed.
Initial reaction attempts included the mutant GFP and a small molecule AlexaFluor- 
488 alkyne, which was a good marker for this reaction due to the ability to easily track 
bioconjugations through fluorescence. A 500 mM solution of Cul and a 500 mM solution 
of TMEDA in H2 O were prepared for use as the catalyst system. The Cul and TMEDA were 
reacted together for 10 minutes at 37 °C to allow equilibration and catalyst complex 
formation. The fluorophore was then added to the catalyst mixture, followed by the GFP 
mutant. Reactions were incubated at either 37 °C or 4 °C in order to determine optimal 
reaction temperatures. Initially, reactions were left overnight. However, once washed and 
analyzed by gel electrophoresis it was discovered that there was a lack of protein in the 
completed reactions, signifying protein degredation. Reaction times were therefore 
decreased to determine optimal time conditions. Overall, the longer reaction times 
showed a decrease in fluorescence and an absence of GFP. It was hypothesized that the 
copper in the catalyst system may be degrading protein throughout the longer time 
periods. To determine the best conditions for the highest yield of bionconjugated protein, 
time courses were performed at both 37 °C and 4 °C. Upon completion, reactions were
analyzed via SDS-PAGE (Figure 7.5) and the ratio of GFP and reaction fluorescence was
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determined and plotted. (Figure 7.6) Ultimately, it was determined that 6  hour reactions 
at 4 °C appeared to be optimal for the Glaser-Hay bioconjugation.
L
Time (h) 6  4 2 1 0.5 6  4 2 1 0.5
■
Coomasie Stain Fluorescence
Figure 7.5: SDS-PAGE analysis of reactions completed between 0.5 and 6 hours, both pre- 
Coomassie Blue staining (for fluorescence) and post staining. The densitometry of each 
band was then measured to generate a ratio of total protein to fluorescently labeled 
protein.
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Figure 7.6: Glaser-Hay timecourse optimization. Ratio of intact GFP to fluorescence of SDS- 
PAGE gel bands. Error bars indicate standard deviation based on readings. Results indicate 
highest %coupling and optimum reaction conditions at 4 °C for 6  hr. Extended periods of 
time lead to protein degradation.
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Upon determining optimal conditions, the reactions were performed using the 
mutant GFP and the same copper/TMEDA catalyst system and the AlexaFluor-488 alkyne. 
Upon reaction completion, any excess fluorophore was removed by centrifugal 
concentration and washed several times with PBS. Reaction products were then analyzed 
via SDS-PAGE and LC/MS.
The gel results demonstrated a successful Glaser-Hay bioconjugation through both 
initial fluorescent imaging combined with Coomassie Blue staining imaging. (Figure 7.7) 
As seen in Lane 2 and 4, with the presence of both the catalyst system and the alkyne 
fluorophore, fluorescent labeling of the GFP is apparent at both 37 °C and 4 °C. A control 
reaction was also performed that did not have the catalyst system introduced. Lane 6  
shows that the control reaction still showed presence of the GFP, but the protein had no 
fluorophore fluorescence, thus confirming the Glaser-Hay coupling of the GFP to the 
alkyne fluorophore by using the copper catalyst system.
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Figure 7.7: Glaser-Hay bioconjugation at both 37 °C and 4 °C. (A) SDS-PAGE analysis after 
Coomassie Blue staining showing the successful incorporation of pPrF into GFP (lane 6  
and 7) due to presence of protein band in 6  and lack of in 7. Bands in 2 and 4 indicate 
presence of conjugated mutant protein upon reaction completion using Glaser-Hay 
conditions. (B) SDS-PAGE analysis indicating successful conjugation of protein to 
fluorophore. The presence of fluorescent bands in lanes 2 and 4 suggest successful 
coupling while lack of fluorescence in lanes 3 and 5 indicate no attached fluorophore.
Overall, this research was able to transition the Glaser-Hay reaction to an aqueous 
environment in order to afford a novel bioconjugation methodology. It was applied 
successfully to protein-fluorophore conjugations, and can be further advanced to include 
other molecules and conjugates. Due to the wide reaction scope, this method could be a
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viable alternative to the popular "click" conjugations and could be further studied to 
optimize all benefits.
B. Toward Glaser-Hay Solid-Support Bioconjugations
To further enhance the scope of the Glaser-Hay bioconjugation method, research 
focus moved to utilizing this reaction for solid-support protein immobilizations. Initial 
efforts toward this focused on applying reaction conditions to a propargyl alcohol 
derivatized Sepharose resin12 and the AlexaFluor fluorophore alkyne. A control reaction 
was conducted without the presence of the copper catalyst system to assess that there 
was not non-specific coupling to the resin. Previously established reaction conditions were 
employed. Upon reaction completion the resin was washed several times with aliquots of 
PBS to eliminate any excess fluorophore, and results were viewed by fluorescent imaging. 
(Figure 7.8) Fluorescence was only viewed in the reaction that had contained the copper 
catalyst, indicating success of the propargyl alcohol resin with the fluorophore.
Cul/TMEDA - +
Fluorophore + +
Figure 7.8: Propargyl alcohol immobilized Sepharose resin reacted with an alkynyl 
fluorophore.
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Attempts were then made to translate this methodology to the coupling of protein 
with the immobilization resin. An immobilized protein could be employed for further 
reactions or as a biorthogonal handle for biological applications. The GFP-pPrF-151 
mutant was again used alongside of either a propargyl alcohol or a hexynol immobilized 
Sepharose resin. Using the optimized Glaser-Hay conditions, the protein was reacted with 
the immobilized resin for 6  hours at 4 °C and upon completion was concentrated by 
centrifugation and washed five times with PBS to eliminate any excess or unreacted 
protein. The purified reactions were then viewed with fluorescent imaging. (Figures 7.9 
and 7.10)
Cul/TMED + - +
GFP-pPrF-151 - + +
Figure 7.9: Reaction including the mutant protein and immobilized propargyl alcohol 
Sepharose resin. Strong fluorescence in the presence of both catalyst and GFP-pPrF-151 
indicate a successful coupling. Lack of fluorescence in control reactions not containing 
protein or copper catalyst indicate no coupling.
Figure 7.9 depicts three reactions using the propargyl alcohol Sepharose resin. One
control reaction was performed in the absence of protein and there is no fluorescence
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observed after resin washing. Another control reaction was conducted with protein and 
resin but no copper catalyst system. Gratifyingly, there was also no fluorescence viewed 
upon reaction purification. However, in the reaction with the immobilized resin, GFP-pPrF- 
151, and Cul/TMEDA a bright fluorescence signal was observed indicating the successful 
coupling of the GFP mutant to the immobilized Sepharose resin. Figure 7.10 shows the 
same reaction and controls performed with a hexynol immobilized resin.
Protein - + +
C ul/TM ED A + - +
Figure 7.10: Bioconjugation of GFP-pPrF-151 with the hexynol derivatized Sephorose 6 B 
resin. In the absence of either GFP or Cul/TMEDA catalyst, no fluorescence is observed; 
however, when all reaction components are present, successful immobilization of the GFP 
protein to the resin solid support is observed.
Reactions were then analyzed using a fluorescence detection multi-well plate 
reader and plotted to determine the relative fluorescence intensity of the control reaction 
versus the successful resin/protein coupling reactions. (Figure 7.11) It can be seen that 
the RFU of the Glaser-Hay reactions are about lOx higher than the RFU of the controls, 
further indicating the success of the Glaser-Hay reaction conditions to couple protein and 
an immobilized resin.
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Figure 7.11: Fluorescence data of completed reactions with both propargyl alcohol and 
hexynol loaded Sepharose resins. Controls with no catalyst system indicate low 
background fluorescence attributed to only the resin, while mutant protein reacted with 
the catalyst and resin shows strong fluorescence. Standard deviations depicted in error 
bars.
III. Materials and Methods
General
Solvents and reagents, including the AlexaFluor 488 Alkyne, were obtained from either 
Sigma-Aldrich or Fisher Scientific and used without further purification. Epoxy-activated 
Sepharose 6 B was obtained from GE Healthcare. Reactions were conducted under 
ambient atmosphere with solvents directly from the manufacturer. All GFP proteins were 
purified according to manufacturer's protocols using a Qiagen Ni-NTA Quik Spin Kit. 
Samples were analyzed on an Agilent 6520 Accurate-Mass Quadrupole-Time-of-Flight (Q- 
TOF) mass spectrometer equipped with an electrospray (ESI) ionization source and liquid 
chromatography (LC) (Agilent). Ionization settings were: positive mode; capillary voltage 
3500 kV; fragmentor voltage 200 V; drying gas temperature 350 °C. Instrument was set
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to standard 2 GHz, extended dynamic range and deconvolution was performed by Agilent 
MassHunter Qualitative Analysis software using the maximum entropy setting. To 
separate analyte a 2.1x150 mm, C8  reverse phase, wide pore (5 pm, 300 A, Phenomenex) 
column was used with a water (A)/acetonitrile (B) (0.1% formic acid) gradient (2% B for 3 
min, followed by a 2-95% B gradient over 15 min, and 95% B for 7 min).
Glaser-Hay Aqueous Conditions
Aqueous conditions for the Glaser-Hay reaction were optimized by preparing a 
phenylacetlyene homodimer. To a vial containing H2 O (3 mL) was added TMEDA (10 uL,
0.06 mmol) and Cul (10 mg, 0.05 mmol), forming the catalyst complex. Phenylacetylene 
(37 mg, 0.364 mmol) was then added and the reaction was allowed to stir at room 
temperature for 16 h. The reaction was extracted using EtOAc and H2 O washes (4 x 5 mL 
ea.), concentrated and dried in vacuo. The product was obtained as a white solid : 8 8  mg,
0.349mmol, 96% yield; XH NMR (400 MHz; CDCI3 ): 6  7.38-7.56 (m, J = 7.2 Hz, 10H).
Expression of GFP-pPrF-151
Escherichia coli BL21(DE3) cells were co-transformed with a pET-GFP-TAG-151 plasmid 
(0.5 pL) and pEVOL-pPrF plasmid (0.5 pL) using an Eppendorf electroporator. Cells were 
then plated on LB-agar plates supplemented with ampicillin (50 mg/mL) and 
chloramphenicol (34 mg/mL) and grown at 37 °C. After 16 h, single a single colony was 
selected and used to inoculate LB media (4 mL) supplemented with ampicillin and 
chloramphenicol. The culture was grown at 37 °C for 12 h. The culture was used to begin 
an expression culture of LB media (10 mL) at OD6 0 0  0.1, then incubated at 37 °C, to an 
OD6 0 0  of ~0.6, at which point cells were induced with 1 M IPTG (10 uL), 20% arabinose (10 
pL) and 100 mM pPrF (100 pL). Cultures were grown for an additional 16 h at 37 °C, then 
harvested by centrifugation (10 min at 10,000 rpm). The media was decanted and the cell 
pellet placed in the -80 °C freezer for at least 20 min. Purification was accomplished using
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commercially available Ni-NTA spin columns and according to manufacturer's protocol. 
Protein yield and purity was assessed by SDS-PAGE, LC/MS, and spectrophotometrically 
using a Nanodrop spectrophotometer.
Protein-Fluorophore Glaser Hay Bioconjugation
The expressed GFP-pPrF-151 was coupled to AlexaFluor 488 alkyne using Glaser-Hay 
reaction conditions. In an eppendorf tube, 500 mM Cul (5 pL) and 500 mM TMEDA (5 pL) 
were mixed and equilibrated at 37 °C. After 10 minutes, 100 mM AlexaFluor 488 alkyne 
(10 pL) was added and equilibrated at 37 °C for 10 min. Finally, GFP-pPrF-151 (20 pL, 0.5 
mg/mL) was added. A control reaction was also prepared with the same concentrations 
of fluorophore and protein, but with the catalyst system replaced with PBS buffer (10 pL). 
The reactions were incubated for various times at 37 °C. Reactions were then purified 
through centrifugal concentration on Spin-X UF colums (Corning), with wash cycles of PBS 
buffer (5 x 100 pL) until flow-through was free of fluorophore. The protein was then 
analyzed by SDS-PAGE gel to verify coupling of the fluorophore to the protein. Timecourse 
experiments were analyzed by comparing densiometry of fluorescent bands to their 
Coomasie Blue stained bands using a Biorad Molecular Imager Gel Doc XR+ system.
Immobilization of Alkynes onto Sepharose Resin
Epoxy-activated 6 B Sepharose (GE Healthcare, 200 mg) was added to a filter syringe and 
washed with dH2 0  ( 5 x 3  mL). Alkyn-ol (700 pmol) and coupling buffer (3.5 mL, pH 13.0) 
were added to a 15 mL falcon tube followed by the resin. The mixture was incubated at 
room temperature for 16 h. The resin was then transferred to a filter syringe and washed 
with coupling buffer ( 5x4  mL), and transferred to a 15 mL falcon tube with ethanolamine 
(3.5 mL). The resin was incubated at 30 °C for 4 h then washed in a filter syringe with 10 
mM acetate buffer (pH 4) and Tris-HCI buffer (pH 8 ) for 3 cycles (4 mL ea.)
104
Attaching Immobilized resin to Protein
The expressed GFP-alkyne was then coupled to the immobilized resin using the Glaser- 
Hay reaction conditions. To eppendorf tube, 5 pL Cul (500 mM) and 5 pL TMEDA (500 
mM) were combined and equilibrated at 37 °C for 10 minutes. To the Eppendorf was 
added 30 mg of immobilized resin and again equilibrated at 37°C. After an additional 10 
minutes, 20 pL of concentrated GFP-alkyne was added. A control reaction was also set up 
using 30 mg immobilized resin, 20 pL GFP-alkyne, and 10 pL PBS buffer. The reactions 
were allowed to shake at 37 °C for six hours, 170 rpm. After six hours, reactions were 
washed on filter columns using PBS buffer (200 pL aliquots x 10). The washed resin- 
protein mixture was transferred to an Eppendorf tube and imaged for fluorescence.
Resin-Fluorophore Glaser Hay Conjugation
The alkyne derivatized resin was reacted under previously described conditions with the 
AlexaFluor 488. To an eppendorf tube, 500 mM Cul (5 pL) and 500 mM TMEDA (5 pL) 
were mixed and equilibrated at 37 °C for 10 min. Alkyne derivatized Sepharose (30 mg) 
was added and equilibrated at 37 °C. After an additional 10 minutes, 100 mM AlexaFluor 
488 alkyne (5 pL) was added. A control reaction was also performed using 30 mg 
immobilized resin, AlexaFluor 488 alkyne (5 pL), and 10 pL 100 mM PBS buffer. The 
reactions were allowed to incubate at 37 °C for 6  h. The reactions were then washed on 
filter columns using 100 mM PBS buffer (10 x 200 pL). The fluorophore derivatized resin 
was transferred to an eppendorf tube and imaged for fluorescence using a BioRad 
Molecular Imager Gel Doc system.
Protein-Resin Glaser Hay Immobilization
The alkyne derivatized resin was reacted under previously described conditions with the
GFP-pPrF-151 protein. To an eppendorf tube, 500 mM Cul (5 pL) and 500 mM TMEDA (5
pL) were mixed and equilibrated at 37 °C for 10 min. Alkyne derivatized Sepharose (30
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mg) was added and equilibrated at 37 °C. After an additional 10 minutes, GFP-pPrF-151 
(5 pL, 0.5 mg/mL) was added. . A control reaction was also performed using 30 mg 
immobilized resin, GFP (5 pL), and 10 pL 100 mM PBS buffer. The reactions were allowed 
to incubate at 37 °C for 6  h. The reactions were then washed on filter columns using 100 
mM PBS buffer (10 x 200 pL). The protein immobilized resin was transferred to an 
eppendorf tube and imaged for fluorescence using a BioRad Molecular Imager Gel Doc 
system.
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Chapter 8-Natural Product Synthesis
I. Introduction
As described in Chapter 4, polyynes, or molecules containing an acetylenic 
scaffold, are known core structures in various natural products. 1 ' 3 Over 1,000 of these 
naturally occurring molecules have been isolated from organisms such as plants, fungi, 
and coral. 2 These structures exhibit numerous biological activities including antibacterial, 
antifungal, anti-HIV, and anticancer properties . 3 ' 4 Therefore, synthetic routes to the 
preparation of these structures are necessary to further study their benefits and develop 
novel therapeutic analogs. Herein, we describe the utilization of our previously developed 
solid-supported Glaser-Hay methodology in order to synthesize some of these key 
polyyne natural products.
II. Results and Discussion
A. Using Solid-Supported Glaser-Hay couplings fo r  Natural Product Synthesis
i. Toward Synthesis of 2,4-dodecadiynyl alcohol
Many corals have been found to be rich in natural products that contain 
antibacterial, antifungal and cytotoxic properties. Specifically, numerous acetylenic 
polyynes have been isolated from the genus M ontipora, a velvet coral. 5 One common 
product isolated is a diyne with a 7-carbon alkyl chain on one end and an alcohol on the 
other (71) (Figure 8.1).
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Figure 8.1: 2,4-dodecadiynyl alcohol, a natural product isolated from M ontiporo  is known 
to possess antibacterial properties, and has also been shown to exhibit cytotoxicity 
against human tumor lines. 2
Numerous research groups have described the synthesis of this compound . 6 -7 ' 9 ' 10 
For example, Stefani et al. report this synthesis as seen in scheme 8.1a, with a reported 
yield of 76%.10 However, this reported synthesis requires hazardous reagents, and 
requires a precursor step to synthesize the halogenated compound. Another reported 
synthesis by Fiandanese et al. can be seen in scheme 8.1b, and requires numerous and 
sometimes harsh reagents, six synthetic steps, and only results in a 42% yield . 9 This 
synthesis also required tedious purification steps post-reaction.
Scheme 8.1
^  n-BuLi, l2 ,c A  pyrrolidine ^ 1
^  ^  ^   ►  . r  ' '' " - '________________ ,_  76o/o
HO
b) a) MeLi-LiBr c) K2C 0 3, n-BuLl in Hexane f— /
 ____ T . . „  MeOH —  —  -8 0 C ,N 2 ,-----
TM S — EE5— eei— TMS ---------------►  /  =  = =  TMS ---------------------- ►  / =  =  --------------------------------------------------     /
HO HO ' —  /o
b) CH20 . Et20  e) HMPA HO
-30C , 15 hr
f) rt; extraction; column
We recognized that this polyyne is an asymmetric diyne and could be synthesized 
using the previously developed solid-supported Glaser-Hay coupling methodology . 8 In 
doing so, this asymmetric natural product could be synthesized using mild reaction 
conditions. By using a solid-support, a propargyl alcohol derivatized resin could be reacted
under Glaser-Hay conditions with a nine carbon terminal alkyne (1-nonyne) to afford 71
(Scheme 8.2). 
Scheme 8.2
—c
1) Cul, TMEDA 
60C, 16 hr., THF
^  HO\ ^ ^  71
2) 2% TFA, rt, 1 hr.
Using a trityl chloride resin with immobilized propargyl alcohol and a copper 
lodide/TMEDA catalyst complex, a carbon bond is formed between 1-nonyne and 
propargyl alcohol. This initial reaction afforded the desired asymmetrical diyne still 
attached to the resin bead. Upon cleavage with trifluoroacetic acid in step 2, the desired 
asymmetrical natural product is obtained. Gratifyingly, upon initial reaction attempts, the 
desired product was obtained in 75% yield and in essentially a single synthetic step. Upon 
reaction completion, the product was purified through a quick silica plug. It was then 
analyzed via 1H NMR and 13C NMR. Spectral data was in accordance with previously 
reported literature values. 9 Overall, utilizing the solid-supported Glaser-Hay methodology 
to synthesize this product eliminated harsh reagents, halogenated precursor compounds, 
and synthetic steps required in previously reported syntheses, and produced the product 
in a better or comparable yield.
ii. Toward Synthesis of Montiporic Acid A
As noted, the coral genus M ontipora  possesses numerous biologically active 
polyyne natural products. A derivative of 71 described above, Montiporic Acid A (72) is
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another common isolated polyyne from this velvet coral species (Figure 8.2 ) . 2 Formerly, 
Montiporic Acid A has been isolated from the eggs of this coral and was shown to possess 
significant cytotoxicity against P-338 murine leukemia cells. It has also been proven to be 
an efficient antibacterial agent against E. coli. 9
Figure 8.2: Montiporic Acid A, typically isolated from M ontipora  and known to possess 
antibacterial properties toward E. coli and also shown to exhibit cytotoxicity against P- 
338 murine leukemia cells.
A successful synthetic approach of Montiporic Acid A was developed by Stefani et 
al. in 1999. In their synthesis, this research group converted 1-nonyne to 1-iodo-l-nonyne 
by treatment with n-BuLi and Iodine. This product was then coupled with propargyl 
alcohol in the presence of pyrrolidine/Cul to produce dodeca-2,4-diynol (71). (Scheme 
8.1a) The synthesis concluded with the reaction of this product with ethyl 2- 
bromoacetate and an (n-8 u)4 NHS0 4 /K 0 H complex to afford Montiporic Acid A. The total 
synthesis reported by Stefani et. al. of Montiporic Acid A resulted in a 56% yield . 10 
Fiandese et. al. report the same approach to the desired montiporic acid A using 71 as a 
starting material and are able to obtain the desired product in a 34% net yield. Overall, 
what varied was these two groups' synthetic routes to the desired polyyne starting 
material (71) (See scheme 8.1). As described, both of these synthetic schemes required
OH
1
O 72
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numerous synthetic steps and harsh reagents. We envisioned that by using our previously 
developed solid-supported Glaser-Hay methodology to synthesize the precursor, 71, with 
mild reaction conditions, we would provide a means to synthesize the desired Montiporic 
Acid A in fewer reaction steps, with mild reaction conditions, and higher purity due to the 
use of the solid support.
As noted, our approach using the solid-supported Glaser-Hay reaction 
methodology was successful for 71. Therefore, efforts moved forward in order to use this 
synthesized natural product to obtain Montiporic Acid A. A reaction protocol from the 
literature9 was followed, adding ethyl 2 -bromoacetate to the polyyne precursor and using 
tetrabutylammonium bisulfate as a phase transfer catalyst. (Scheme 8.3)
Scheme 8.3
1 )5 0 %  KOH 
Toluene
HO (n-Bu)4N H S 0 4 _
\  — ...... .—  ... n  10C. 3 hr. \— — \  + B r ^ y  "i  ► O —x
\  O 1 2) HCI \7  4   , 1 \__
'  1 \__ Montiporic Acid A
^  72
Following the reaction, an extraction was performed using consecutive washes of 
DCM and H2 O. The product was then analyzed via XH and 13C NMR. Results indicated that 
by using our previously synthesized 71 precursor for the reaction, the desired product 
was formed in a net yield of 49%. Analysis shows product in moderate to good purity but 
future work is required to further purify the desired Montiporic Acid A and increase the 
synthetic yield.
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iii. Toward Synthesis of Octatriyn-l-ol
Fungi can also be a rich source of polyyne natural products. Octatriyn-l-ol, 
pictured in figure 8.3 (73), was originally isolated by Hearn and coworkers from an edible 
mushroom, Kuehneromyces m utabilis.11 This molecule, as well as similar structures were 
shown to possess antibacterial activities.
Figure 8.3: Octatriyn-l-ol, formerly isolated from fungi and shown to have antibacterial 
activity.
This product has been synthesized successfully by means of a Fritsch Buttenberg-Wiechell 
rearrangement by Luu et al. 12 The protocol for the generation of the triyne core 
performed by this group can be seen in scheme 8.4.
Scheme 8.4
HOV
73
o
HO
V
a,b c
X
OH
OH TBDPS
TBDPS
d,e
/
OH .A
/TBDPS
a)TBDPSCI, THF, Et3 N, DMAP; b) BaMn04; c) CH3 CCLi, LiBr, THF, -78 °C; d) BaMn04; e) CBr4,
PPh3, CH2 CI2 , Et3 N, 0 °C; f) BuLi, hexanes, -78 °C; g) TBAF, THF, -20 °C. 12
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Overall, this previously reported synthesis requires eight synthetic steps to 
generate the compound. This reported methodology also requires numerous reagents- 
some hazardous, and careful reaction temperature control leading to an overall yield of 
only 3% . 12
Building on our reported methodology and protocol for extending the acetylenic 
scaffold, 8 1 3  here we report a synthetic route toward Octatriyn-l-ol (Scheme 8.5), 
decreasing the synthetic steps and number of reagents used from previous reports as well 
as increasing yield. Beginning with a propargyl alcohol immobilized resin, a TMS group 
was added using the Glaser-Hay reaction. The TMS group was then cleaved using a TBAF 
solution, regenerating the terminal alkyne. Propyne was then coupled to the resin using 
the Glaser-Hay reaction and the product was cleaved with a 2% TFA solution, affording 
the desired asymmetrical triyne natural product, 73.
Scheme 8.5
Cul, TMEDA 
60C, 16 hr., THF
Si
/  1M TBAF, 1 hr, rt
Q  o ' * ~ Q - °
Cul, TMEDA 
60C, 16 hr., THF
= “ CH3 |
2% TFA, rt, 1 hr.
HO 73
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Utilizing our described methodology, and employing a silica plug using 5:1 
hexanes:EtOAc for purification, we have been successful at the synthesis of 73 
(characterization data may be found in Materials and Methods). This compound was 
acquired in good purity and with a yield of 6 8 %.
iv. Toward Synthesis of Agrocybin
Another natural product found in fungi is agrocybin, originally isolated from 
Agrocybe dura.2 Naturally, this molecule is released by Agrocybe dura during the fruiting 
season as an antifungal agent. Furthermore, it has been shown to exhibit antibacterial 
properties. This product has a triyne core and an amide capping group. (Figure 8.4)
___________________ O
HO7 NH2
74
Figure 8.4: The structure of Agrocybin, originally found in the fungi species Agorocybe 
dura and known to possess important antifungal and antibacterial properties.
A similar approach used to access 73 was attempted to synthesize agrocybin. 
Based on a previously established protocol, 8 ' 13 a known methodology is available for 
preparation of the alcohol and the extended polyyne core. We then envision adding the 
desired cap, propiolamide, in order to generate the product via the Glaser-Hay reaction. 
Upon reaction completion, the cleaved material required quick purification via a short 
silica plug (Scheme 8 .6 ) yielding 74.
115
Scheme 8.6
Cul, TMEDA  
/  60C, 16 hr., THF
S i . ,
1M TBAF, 1 hr, rt
■Sr
* 0 -0 * 0 - 0
Cul, TM EDA  
60C, 16 hr., THF 
O— / '
o 2% TFA, rt, 1 hr. OM
HO
74
NH2
A Glaser coupling approach to agrocybin synthesis was successfully performed by 
Jente and co-workers in 1984 to allow NMR studies on this molecule and its derivatives. 14 
. To synthesize the agrocybin, this research group employed Glaser reaction conditions 
with an extended propargyl alcohol and propiolamide. Because of the chemoselectivity 
limitations associated with the Glaser protocol (See Chapter 4), further purification was 
necessary and yields were reported as only 30%.14 We hope that utilization of our novel 
solid-supported Glaser-Hay methodology will drastically increase the yield of this product 
and provide a direct route to its synthesis. Unfortunately, initial attempts to obtain this 
product using our methodology (Scheme 8.4) did not indicate the presence of product 
upon NMR analysis. Future work needs to be employed, including potentially protecting 
the propiolamide prior to coupling as well as scaling up the reaction and completely 
purifying the completed product for accurate analysis.
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v. Toward Synthesis of phenylhepta-2,4,6-triynyl acetate
The last natural product we attempted to synthesize in order to demonstrate the 
utility of the solid-supported Glaser-Hay methodology was 75. This acetate polyyne has 
been isolated from several species of Bidens in the Aster family of plants and has shown 
antibacterial properties. 2 (Figure 8.5)
/  75
Figure 8.5: Natural product phenylhepta-2,4,6-triynyl acetate consisting of a triyne core 
asymmetrically capped with a phenyl group and an acetate group. This product has been 
previously isolated from many plants species including Bidens. 2
A previously reported synthesis uses a starting material of 1,4 butynediol and 
TBDPS as a protecting group in order to react with a lithiated phenylacetylene and 
undergo further cycles of Fritch-Butenberg-Wiechell rearrangements to produce the 
triyne core. 12 (Scheme 8.7)
Scheme 8.7
HO k  . c d' h _  0J.  ^   ► // \\ — — — r  \
OH
OTBDPS OTBDPS
a) TBDPSCI, DMAP, THF; b) BaMn04, CH2 CI2; c) PhCCLi, THF, -78°C; d) BaMn04; CH2 CI2, rt 
e) CBr4, PPh3, CH2 CI2/ Et3 N, 0 °C; f) BuLi, hexanes, -78 °C; g) TBAF, THF, rt; h) Ac2 0, DMAP, 
NEts, CH2 CI2, rt.
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This methodology is similar to that shown in Scheme 8.4 performed by the same 
research group, and totals eight synthetic steps to achieve the desired product. It also 
requires numerous reagents, sometimes harsh, and only affords the product in a 14% 
yield . 12 Here we propose utilizing our previously reported molecule 44 13 and envision 
simply acetylating the alcohol to yield 75. (Scheme 8 .8 ) Overall, our methodology employs 
mild reaction conditions and eliminates synthetic steps from the previously reported 
synthesis.
Scheme 8 . 8
Cul, TMEDA 
60C, 16 hr., THF 1M TBAF, 1 hr. rt
■ Q - c O  c
Cul, TMEDA 
60C, 16 hr., THF
/ = \  Ac20 , DMAP, DCM
A /) ----------- / ~ \//•
2% TFA, rt, 1 hr.
A /)
The previously described Glaser-Hay coupling with TMS followed by TBAF induced 
TMS deprotection was employed to prepare the immobilized polyyne core, and the 
polyyne was capped with phenylacetylene. The solid-support was then cleaved to afford 
the triynol product. The alcohol was acetylated with acetic anhydride in the presence of 
DMAP to afford the desired product. Upon acetylation, the reaction was extracted and 
washed with DCM/H 2 O and dried with MgSC>4 . The triyne 75 was then purified on a silica 
column with 5:1 Hex/EtOAc. This synthesis afforded the desired natural product, which
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was then analyzed via NMR. (9 mg, 0.041 mmol, 46%) Utilizing the solid supported Glaser- 
Hay methodology we were able to eliminate synthetic steps as well as harsh and excessive 
reagents, and drastically improve the yield of this natural product.
Overall, we have shown that solid-supported Glaser Hay reactions are a useful 
methodology in the synthesis of natural products. Due to possible purification issues 
throughout the reactions, and small reaction scales, more research is required in order to 
obtain pure products and hopefully increase the yields provided by the methodology. 
Future work will employ examining these products for biological activity in an anti­
bacterial screen in order to potentially elucidate new therapeutic agents.
III. Materials and Methods
General. Solvents and reagents were obtained from either Sigma-Aldrich or Fisher 
Scientific and used without further purification, unless noted. Tritylchloride resin, 100- 
200 mesh, 1% DVB crosslinking, was purchased from Advanced Chemtech. Reactions 
were conducted under ambient atmosphere with non-distilled solvents. NMR data was 
acquired on a Varian Gemini 400 MHz. GC/MS analysis was conducted on an Agilent 
Technologies 6890N GC system interfaced with a 5973N mass selective detector. An 
Agilent J&W GC capillary column (30 m length, 0.32 mm diameter, 0.25 nm film) was 
employed with a splitless injection (250 °C inlet, 8 . 8  psi) with an initial 70 °C hold (2 min) 
and ramped for 15 min to 230 °C.
Immobilization of Alcohol onto Trityl Chloride Resin in Low Loading Conditions
Trityl chloride resin (200 mg, 0.36 mmol, 1 equiv.) was added to a flame dried vial charged 
with dichloromethane (5 mL). The resin was swelled at room temperature with gentle
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stirring for 15 min. Alcohol (25.0 pL, ~1.2 equiv.) was added to reaction, followed by 
triethylamine (10.0 pL, 0.072 mmol, 0.2 equiv). The mixture was stirred at room 
temperature for 16 h. The resin was transferred to a syringe filter and washed with DCM 
and MeOH (5 alternating rinses with 5 mL each). The resin was swelled in CH2 CI2 and dried 
under vacuum for 45 min before further use.
Polyyne Extension Protocol
Trimethylsilylacetylene (160 pL, 1.05 mmol, 15 equiv.) was added to a flame dried vial 
containing the alcohol derivatized trityl resin (100 mg, 0.07 mmol, 1 equiv.), and 
tetrahydrofuran (2.0 mL). The Cul (20 mg, 1.06 mmol) and tetramethylethylenediamine 
(20 pL, 0.132 mmol.) were added to a separate flame-dried vial then dissolved in 
tetrahydrofuran (2.0 mL). The catalyst mixture was then added to the resin in one portion 
and stirred at 60 °C for 16 h. The resin was transferred to a syringe filter and washed with 
DCM and MeOH (5 alternating rinses with 5 mL each). The TMS group was then cleaved 
by incubation in 1M tetra-n-butylammonium fluoride trihydrate in DCM (TBAF, 1 mL, 1 h). 
Then the reaction was again transferred to a syringe filter and washed with DCM and 
MeOH (5 alternating rinses with 5 mL each) and dried under vacuum for 45 minutes. 
Product was weighed and transferred to flame dried vial for future use.
71. 2,4-dodecadiynyl alcohol. 1-Nonyne (115 pL, 0.70 mmol, 10 equiv.) was added to a
flame dried vial containing the propargyl alcohol derivatized trityl resin (100 mg, 0.070
mmol, 1 equiv.), and tetrahydrofuran (2 mL). The copper catalyst (10 mg, 0.053 mmol,
~0.7 equiv.) and tetramethylethylenediamine (30 pL) were added to a separate flame-
dried vial then dissolved in tetrahydrofuran (2 mL). The catalyst mixture was then added
to the resin in one portion and stirred at 60 °C for 16 h. The resin was transferred to a
syringe filter and washed with DCM and MeOH (5 alternating rinses with 5 mL each). The
product was then cleaved from the resin by treatment with 1 mL 2% TFA (DCM, 1 h), and
filtered into a vial. A short silica plug was utilized to remove unreacted starting material
(1:1 EtOAc/Hex) and pure product was obtained (0.010 g, 0.052 mmol, 75%). 1H NMR:
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400 MHz, CDCI3: 6  = 4.27 (s, 2H), 2.24 (t, J = 7.2 Hz, 2H), 1.55 (quint, J = 7.2 Hz, 2H), 1.39- 
1.31 (m, 2H), 1.30-1.19 (m, 6 H), 0.90 (t, J = 6.9 Hz, 3H). 13C NMR of Polyyne 1, 400 MHz, 
CDCI3 : 6  = 51.7, 31.8, 29.5, 28.7, 28.1, 22.4, 19.2, 14.0.
XH NMR 71:
13C NMR 71:
Vw m h i  ■»!'■i ’ m1 ■ ■ '*»» <■» 1.. »<pl i
r
10 60 50 40 30 20 10 ppm
72. Montiporic Acid A. Ethyl bromoacetate (10 pL, 0.1 mmol, 2 equiv.) was added at 10 
°C to a vial containing 71 (0.010 g, 0.052 mmol, 1 equiv.) dissolved in toluene (1 mL), 50% 
KOH (200 pL), and tetra-butyl ammonium sulfate (10 mg, 0.03 mmol, ~0.5 equiv.). The 
reaction was then vigorously stirred at 10 °C for 3 hours. Upon completion, the reaction
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was quenched with dilute HCI (5 mL), extracted with EtOAc, and washed with H2 O. (3x5 
mL) The product was then dried over anhydrous MgSCU and solvent removed in vocuo. 
Purification was performed via column chromatography (hexanes: EtOAc 10:1 to 1:3) to 
yield the desired product ( 8  mg, 0.039 mmol, 49%). 1H NMR: 400 MHz, CDCI3: 6  = 4.38 (s, 
2H), 4.21 (s, 2H), 2.24 (t, J = 7.2 Hz, 2H), 1.49 (quint, J = 7.2 Hz, 2H), 1.34-1.31 (m, 2H),
1.29-1.19 (m, 6 H), 0.84 (t, J = 6.9 Hz, 3H)
*H NMR 72:
__
73. Octatriyn-l-ol. The previously described polyyne extension protocol was used to 
obtain the immobilized terminal alkyne diyne. 1-Propyne (53 pL, 0.70 mmol, 10 equiv.) 
was added to a flame dried vial containing the immobilized resin (100 mg, 0.07 mmol, 1 
equiv.) and tetrahydrofuran (2 mL). The copper catalyst (10 mg, 0.053 mmol, ~0.7 equiv.) 
and tetramethylethylenediamine (30 pL) were added to a separate flame-dried vial then 
dissolved in tetrahydrofuran (2 mL). The catalyst mixture was then added to the resin 
reaction in one portion and stirred at 60 °C for 16 h. The resin was transferred to a syringe 
filter and washed with DCM and MeOH (5 alternating rinses with 3 mL each). The product 
was then cleaved from the resin by treatment with 1 mL 2% TFA (DCM, 1 h), and filtered
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into a vial. A short silica plug was performed to remove unreacted starting material (5:1 
EtOAc/Hex), affording product 73. (0.004 g, 6 8 %) 1H NMR of Triynol: 400 MHz, CDCb: 
<5 = 4.70 (s, br, 1H), <5 = 4.34 (s, 2H), 1.96 (s, 3H)
*H NMR 73:
74. Agrocybin. The previously described polyyne extension protocol was used to obtain 
the immobilized terminal alkyne diyne. Propiolamide (10 equiv.) was added to a flame 
dried vial containing the starting material (lOOmg) and tetrahydrofuran (4 mL). The 
copper catalyst (10 mg, 0.053 mmol) and tetramethylethylenediamine (30 pL) were 
added to a separate flame-dried vial then dissolved in tetrahydrofuran (1 mL). The catalyst 
mixture was then added to the resin reaction in one portion and stirred at 60 °C for 16 h. 
The resin was transferred to a syringe filter and washed with DCM and MeOH (5 
alternating rinses with 3 mL each). The product was then cleaved from the resin by 
treatment with 1 mL 2% TFA (DCM, 1 h), and filtered into a vial. A short silica plug was 
attempted to remove unreacted starting material (EtOAc/Hex).
75. phenylhepta-2,4,6-triynyl acetate. The previously described polyyne extension 
protocol was used to obtain the immobilized terminal alkyne diyne. Phenylacetlyene
T
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(0.70 mmol, 10 equiv.) was added to a flame dried vial containing the starting material 
(100 mg, 0.070 mmol, 1 equiv.) and tetrahydrofuran (2 mL). The Cul (10 mg, 0.053 mmol) 
and tetramethylethylenediamine (30 pL) were added to a separate flame-dried vial then 
dissolved in tetrahydrofuran (2 mL). The catalyst mixture was then added to the resin 
reaction in one portion and stirred at 60 °C for 16 h. The resin was transferred to a syringe 
filter and washed with DCM and MeOH (5 alternating rinses with 5 mL each). The product 
was then cleaved from the resin by treatment with 1 mL 2% TFA (DCM, 1 h), and filtered 
into a vial. Solvent was removed in vacuo to afford the 7-phenyl-trynol (10 mg, 0.056 
mmol, 80%) Acetic anhydride (1 mL) and a catalytic amount of DMAP were added and 
dissolved in 1 mL DCM. The reaction was allowed to stir at room temperature for 3 hr, 
followed by an extraction using DCM/H 2 O (3x5 mL) and drying with MgS04. The product 
was then purified on a silica gel column using 5:1 hex:EtOAc yielding 75 (9 mg, 0.041 
mmol, 46%), which was then analyzed via 1H NMR: 400 MHz, CDCI3 : 6 = 7.40-7.25 (m, 5H), 
4.35 (s, 2H), 1.96 (s, 3H).
XH NMR 75:
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